
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Obesity enhances ovarian cancer chemotherapy efficacy through C1q-mediated tumor targeting and immune activation - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE5315A68AEF76330515A60000F1E3CE.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="nanobio">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372299/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Journal of Nanobiotechnology">
<meta name="citation_title" content="Obesity enhances ovarian cancer chemotherapy efficacy through C1q-mediated tumor targeting and immune activation">
<meta name="citation_author" content="Shiyi Xu">
<meta name="citation_author_institution" content="National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074 China">
<meta name="citation_author" content="Nana Bie">
<meta name="citation_author_institution" content="National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074 China">
<meta name="citation_author_institution" content="Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074 China">
<meta name="citation_author_institution" content="Hubei Key Laboratory of Bioinorganic Chemistry and Materia Medica, Huazhong University of Science and Technology, Wuhan, 430074 China">
<meta name="citation_author" content="Xinzhuang Su">
<meta name="citation_author_institution" content="Schoole of Biological Science, University of Manchester, Manchester, UK">
<meta name="citation_author" content="Xiaojuan Zhang">
<meta name="citation_author_institution" content="National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074 China">
<meta name="citation_author" content="Shiyu Li">
<meta name="citation_author_institution" content="National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074 China">
<meta name="citation_author" content="Haojie Liu">
<meta name="citation_author_institution" content="National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074 China">
<meta name="citation_author" content="Tuying Yong">
<meta name="citation_author_institution" content="National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074 China">
<meta name="citation_author_institution" content="Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074 China">
<meta name="citation_author_institution" content="Hubei Key Laboratory of Bioinorganic Chemistry and Materia Medica, Huazhong University of Science and Technology, Wuhan, 430074 China">
<meta name="citation_author" content="Qing Chen">
<meta name="citation_author_institution" content="Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan, 430060 China">
<meta name="citation_author" content="Xiangliang Yang">
<meta name="citation_author_institution" content="National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074 China">
<meta name="citation_author_institution" content="Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074 China">
<meta name="citation_author_institution" content="Hubei Key Laboratory of Bioinorganic Chemistry and Materia Medica, Huazhong University of Science and Technology, Wuhan, 430074 China">
<meta name="citation_author" content="Lu Gan">
<meta name="citation_author_institution" content="National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074 China">
<meta name="citation_author_institution" content="Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074 China">
<meta name="citation_author_institution" content="Hubei Key Laboratory of Bioinorganic Chemistry and Materia Medica, Huazhong University of Science and Technology, Wuhan, 430074 China">
<meta name="citation_publication_date" content="2025 Aug 22">
<meta name="citation_volume" content="23">
<meta name="citation_firstpage" content="580">
<meta name="citation_doi" content="10.1186/s12951-025-03635-0">
<meta name="citation_pmid" content="40847354">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372299/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372299/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372299/pdf/12951_2025_Article_3635.pdf">
<meta name="description" content="Personalized protein corona significantly influences the biodistribution and therapeutic efficacy of nanomedicines, generating unique profiles that can impact treatment outcomes. Here, we demonstrate that pegylated liposomal doxorubicin (PLD) ...">
<meta name="og:title" content="Obesity enhances ovarian cancer chemotherapy efficacy through C1q-mediated tumor targeting and immune activation">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Personalized protein corona significantly influences the biodistribution and therapeutic efficacy of nanomedicines, generating unique profiles that can impact treatment outcomes. Here, we demonstrate that pegylated liposomal doxorubicin (PLD) ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372299/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Searchâ€¦
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12372299">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s12951-025-03635-0"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/12951_2025_Article_3635.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372299%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12372299/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12372299/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372299/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-nanobio.png" alt="Journal of Nanobiotechnology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Journal of Nanobiotechnology" title="Link to Journal of Nanobiotechnology" shape="default" href="https://jnanobiotechnology.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">J Nanobiotechnology</button></div>. 2025 Aug 22;23:580. doi: <a href="https://doi.org/10.1186/s12951-025-03635-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s12951-025-03635-0</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22J%20Nanobiotechnology%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22J%20Nanobiotechnology%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J%20Nanobiotechnology%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22J%20Nanobiotechnology%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Obesity enhances ovarian cancer chemotherapy efficacy through C1q-mediated tumor targeting and immune activation</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Shiyi Xu</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Shiyi Xu</span></h3>
<div class="p">
<sup>1</sup>National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shiyi Xu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bie%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Nana Bie</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Nana Bie</span></h3>
<div class="p">
<sup>1</sup>National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074 China </div>
<div class="p">
<sup>2</sup>Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074 China </div>
<div class="p">
<sup>3</sup>Hubei Key Laboratory of Bioinorganic Chemistry and Materia Medica, Huazhong University of Science and Technology, Wuhan, 430074 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bie%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Nana Bie</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Su%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Xinzhuang Su</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Xinzhuang Su</span></h3>
<div class="p">
<sup>4</sup>Schoole of Biological Science, University of Manchester, Manchester, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Su%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xinzhuang Su</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Xiaojuan Zhang</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Xiaojuan Zhang</span></h3>
<div class="p">
<sup>1</sup>National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xiaojuan Zhang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Shiyu Li</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Shiyu Li</span></h3>
<div class="p">
<sup>1</sup>National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shiyu Li</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Haojie Liu</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Haojie Liu</span></h3>
<div class="p">
<sup>1</sup>National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Haojie Liu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yong%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Tuying Yong</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Tuying Yong</span></h3>
<div class="p">
<sup>1</sup>National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074 China </div>
<div class="p">
<sup>2</sup>Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074 China </div>
<div class="p">
<sup>3</sup>Hubei Key Laboratory of Bioinorganic Chemistry and Materia Medica, Huazhong University of Science and Technology, Wuhan, 430074 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yong%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tuying Yong</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20Q%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Qing Chen</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Qing Chen</span></h3>
<div class="p">
<sup>5</sup>Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan, 430060 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20Q%22%5BAuthor%5D" class="usa-link"><span class="name western">Qing Chen</span></a>
</div>
</div>
<sup>5,</sup><sup>âœ‰</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Xiangliang Yang</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Xiangliang Yang</span></h3>
<div class="p">
<sup>1</sup>National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074 China </div>
<div class="p">
<sup>2</sup>Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074 China </div>
<div class="p">
<sup>3</sup>Hubei Key Laboratory of Bioinorganic Chemistry and Materia Medica, Huazhong University of Science and Technology, Wuhan, 430074 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xiangliang Yang</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>âœ‰</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gan%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Lu Gan</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Lu Gan</span></h3>
<div class="p">
<sup>1</sup>National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074 China </div>
<div class="p">
<sup>2</sup>Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074 China </div>
<div class="p">
<sup>3</sup>Hubei Key Laboratory of Bioinorganic Chemistry and Materia Medica, Huazhong University of Science and Technology, Wuhan, 430074 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gan%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lu Gan</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>âœ‰</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074 China </div>
<div id="Aff2">
<sup>2</sup>Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074 China </div>
<div id="Aff3">
<sup>3</sup>Hubei Key Laboratory of Bioinorganic Chemistry and Materia Medica, Huazhong University of Science and Technology, Wuhan, 430074 China </div>
<div id="Aff4">
<sup>4</sup>Schoole of Biological Science, University of Manchester, Manchester, UK </div>
<div id="Aff5">
<sup>5</sup>Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan, 430060 China </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>âœ‰</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Apr 9; Accepted 2025 Jul 30; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Â© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the articleâ€™s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the articleâ€™s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12372299Â Â PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40847354/" class="usa-link">40847354</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Personalized protein corona significantly influences the biodistribution and therapeutic efficacy of nanomedicines, generating unique profiles that can impact treatment outcomes. Here, we demonstrate that pegylated liposomal doxorubicin (PLD) exhibits increased tumor accumulation and enhanced antitumor immunity in obese mice bearing ovarian tumor, inducing a greater capacity to inhibit tumor growth compared to normal mice. Mechanistically, the protein corona, particularly enriched with complement component 1q (C1q) in the plasma of obese mice, significantly enhances the internalization of PLD by ovarian cancer cells and elicits strong immunogenic cell death (ICD) effects. Concurrently, C1q adsorbed on PLD promotes the engulfment of apoptotic tumor cells by dendritic cells (DCs), activating T cell-mediated antitumor immune responses and amplifying the overall antitumor efficacy of PLD in obese mice. Our findings provide new insights into the role of the personalized protein corona in modulating the therapeutic response to chemotherapy and highlight the potential of targeting C1q for enhancing the efficacy of nanomedicines in cancer treatment.</p>
<section id="sec1"><h3 class="pmc_sec_title">Graphical Abstract</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372299_12951_2025_3635_Figa_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a62/12372299/f9e866269198/12951_2025_3635_Figa_HTML.jpg" loading="lazy" id="MO1" height="619" width="669" alt="graphic file with name 12951_2025_3635_Figa_HTML.jpg"></a></p></section><section id="sec2"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s12951-025-03635-0.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Protein corona, Pegylated liposomal doxorubicin, Tumor-targeted delivery, Obesity, Complement component 1q</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par36">Nanomedicines hold significant promise in enhancing cancer chemotherapy due to the enhanced permeability and retention (EPR) effects [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>, <a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. However, their clinical benefits have not yet shown substantial superiority over traditional treatments [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>, <a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. A key challenge is the inadequate tumor targeting of chemotherapeutic agents [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>], leading to suboptimal therapeutic outcomes and considerable side effects [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>, <a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. Additionally, responses to these nanomedicines vary widely among individuals, with patient-specific factors such as gender [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>], age [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>] and body mass index (BMI) [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>] influencing drug effectiveness. Thus, enhancing the precision of tumor targeting and elucidating the mechanisms behind individual responses to nanomedicines are crucial for boosting the efficacy of chemotherapeutic agents.</p>
<p id="Par37">Nanomedicines, once in the bloodstream, adsorb proteins from the surrounding media to form protein corona through electrostatic, van der Waals and hydrophobic interactions [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>, <a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>]. This protein corona can alter the physicochemical properties of nanomedicines, thereby affecting their pharmacokinetics, biodistribution and therapeutic efficacy [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>, <a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. For example, the adsorption of opsonins such as IgG can promote phagocytosis by the reticuloendothelial system (RES) and the eventual removal of nanomedicines from systemic circulation, while the adsorption of functional proteins such as albumin can enable active tumor targeting [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. The composition of plasma proteins in patients with different pathological status might be different, leading to significant alterations in the protein corona composition on the nanoparticle surface (named as personalized protein corona) and generating different therapeutic efficacy [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>, <a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. Therefore, an in-depth understanding of personalized protein corona can elucidate the mechanism on different therapeutic efficacy of the same nanomedicines and serve as a potential tool for advancing personalized nanomedicines or overcoming limitations in the clinical translation of nanoparticle-based therapies.</p>
<p id="Par38">Obesity, characterized by a BMI of 30Â kg m<sup>âˆ’2</sup> or higher, is a global epidemic and a significant risk factor for at least 13 types of cancer, including ovarian cancer [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>, <a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]. It often triggers inflammation and elevates levels of leptin and insulin-like growth factor-1 (IGF-1), which can drive tumor development and progression [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>, <a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]. Interestingly, despite its role in promoting tumorigenesis, recent clinical analyses have revealed a paradoxical association between obesity and improved cancer therapeutic outcomes [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>, <a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. Obese patients tend to show better responses to chemotherapy and immune checkpoint blockade therapy [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>, <a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. For example, retrospective analyses of ovarian cancer patient data have revealed that obese patients have higher progression-free survival rates after treatment with chemotherapeutic agents such as PLD, paclitaxel, and carboplatin [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. However, the mechanisms underlying this enhanced therapeutic efficacy in obese patients remain to be fully understood.</p>
<p id="Par39">Ovarian cancer is one of the most lethal cancers in the female reproductive system, with chemotherapy being a primary treatment [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>]. However, unsatisfactory treatment efficacy and chemotherapy-related side effects significantly impact patientsâ€™ quality of life [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. While emerging chemotherapy-related drugs, including chemokinetic therapeutic agents [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>], immunotherapeutic agents [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>, <a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>], and aptamer drugs [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>], show promise, their clinical translation remains challenging. Here, we demonstrate that PLD exhibits stronger anticancer activity in obese mice with ovarian tumors compared to normal mice. PLD adsorbs complement component 1q (C1q), a key component of the classical complement activation pathway [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>, <a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>], from the serum of obese mice, which facilitates its uptake by tumor cells expressing high levels of C1q receptors [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>], thereby efficiently killing tumor cells. Furthermore, C1q adsorbed on PLD promotes the phagocytosis of released tumor antigens by dendritic cells (DCs) via DC-SIGN receptor [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>], activating DC maturation and T cell-mediated antitumor immune responses and significantly enhancing the anticancer efficacy of PLD in obese mice (Scheme <a href="#Sch1" class="usa-link">1</a>). This work highlights a potential mechanism for leveraging personalized protein corona to enhance PLD efficacy and offering a more realistic and clinically translatable approach compared to other nanomedicines.</p>
<figure class="fig xbox font-sm" id="Sch1"><h3 class="obj_head">Scheme 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372299_12951_2025_3635_Sch1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a62/12372299/6d9a0be90a0c/12951_2025_3635_Sch1_HTML.jpg" loading="lazy" id="MO2" height="620" width="669" alt="Scheme 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Sch1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Schematic representation of the enhanced therapeutic sensitivity of PLD in obese mice with ovarian tumors. C1q highly present in plasma of obese mice adsorbs to PLD, leading to increased tumor accumulation and potentiating the ICD response in tumor cells. Concurrently, C1q engagement is essential for facilitating the phagocytosis of apoptotic tumor cells by DCs through DC-SIGN receptor, which activates tumor-specific CD8<sup>+</sup> T cells and significantly improves the anticancer efficacy of PLD in DIO mice</p></figcaption></figure></section><section id="Sec2"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Obesity enhances the therapeutic efficacy of PLD and improves tumor immune microenvironment in ovarian cancer</h3>
<p id="Par41">To assess the impact of obesity on chemotherapeutic efficacy, a diet-induced obesity (DIO) model was first developed by administering a high-fat diet (60% fat diet) to female C57BL/6 mice [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. Concurrently, a control group was maintained on a normal-fat diet (10% fat diet) over the same period. After 13 weeks, the DIO mice gained more than 20% of their initial body weight (Fig. <a href="#MOESM1" class="usa-link">S1</a>A and B) and exhibited a significant increase in Leeâ€™s index, an indicator of obesity calculated as weight<sup>1/3</sup>/Naso-Anal length [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>], compared to the normal mice (Fig. <a href="#MOESM1" class="usa-link">S1</a>C). Additionally, the DIO mice had significantly more gonadal and inguinal fat pads than the control group (Fig. <a href="#MOESM1" class="usa-link">S1</a>D), with a 8.6-fold increase in gonadal fat (Fig. <a href="#MOESM1" class="usa-link">S1</a>E) and a 11.4-fold increase in inguinal fat (Fig. <a href="#MOESM1" class="usa-link">S1</a>F). Blood biochemistry analyses also revealed that the DIO group had substantially higher levels of glucose (Fig. <a href="#MOESM1" class="usa-link">S1</a>G), cholesterol (Fig. <a href="#MOESM1" class="usa-link">S1</a>H), high-density lipoprotein cholesterol (HDL-C, Fig. <a href="#MOESM1" class="usa-link">S1</a>I) and low-density lipoprotein cholesterol (LDL-C, Fig. <a href="#MOESM1" class="usa-link">S1</a>J) compared to normal mice. These findings collectively verify the successful creation of the DIO model.</p>
<p id="Par42">Clinical data have indicated that ovarian cancer patients with a BMI over 30 exhibit improved survival rates following PLD [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. To determine if the obese mice showed a similar response, ID8 ovarian cancer subcutaneous tumor models were established in both normal and DIO mice. These mice were treated with PLD <em>via</em> tail vein injection. The particle size, zeta potential and drug loading of PLD were 81.0â€‰Â±â€‰0.1Â nm (Fig. S2A), âˆ’â€‰1.1â€‰Â±â€‰0.1 mV and 11.1%, respectively. Transmission electron microscopic (TEM) images revealed that PLD has a homogeneous spherical structure (Fig. S2B). Although obesity is generally associated with increased ovarian cancer growth, the DIO mice demonstrated a more effective tumor suppression effect after PLD treatment (Fig.Â <a href="#Fig1" class="usa-link">1</a>A). Specifically, PLD treatment led to a 74% reduction in tumor weight in obese mice, a significantly greater decrease compared to the normal mice group (Fig.Â <a href="#Fig1" class="usa-link">1</a>B). Additionally, the survival period for the PLD-treated obese mice was extended to 44 days, which was notably longer than the 34 days observed in the PLD-treated normal mice group (Fig.Â <a href="#Fig1" class="usa-link">1</a>C). These data suggest that obesity might enhance the effectiveness of PLD treatment in ovarian cancer. Specifically, PLD treatment was found to induce cardiotoxicity in the normal group of mice, as demonstrated by hematoxylin and eosin (H&amp;E) staining of key organs (Fig. S3), serological analysis (Fig. S4) and reduced body weight (Fig. S5). In contrast, obesity appeared to reduce the systemic toxicity associated with PLD (Fig. S3-S5), confirming a protective role of obesity against the adverse effects of chemotherapy [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>].</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372299_12951_2025_3635_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a62/12372299/b97c5bc6dba9/12951_2025_3635_Fig1_HTML.jpg" loading="lazy" id="MO3" height="802" width="669" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Effects of obesity on the anticancer activity of PLD in ID8 tumor-bearing mice. <strong>A</strong> Tumor growth curves of ID8 tumor-bearing normal and DIO mice after intravenous injection of PBS or PLD at the DOX dosage of 4Â mg kg<sup>âˆ’1</sup> once every other day for 3 times. Data are presented as meansâ€‰Â±â€‰SD (<em>n</em>â€‰=â€‰8). <strong>B</strong>Â Tumor weights at day 13 of the treatment indicated in (<strong>A</strong>). Data are presented as meansâ€‰Â±â€‰SD (<em>n</em>â€‰=â€‰6). <strong>C</strong> Kaplanâ€“Meier survival plot of ID8 tumor-bearing normal and DIO mice after treatment indicated in (<strong>A</strong>) (<em>n</em>â€‰=â€‰8). <strong>D</strong>, <strong>E</strong>Â In vivo CellVue<sup>Â®</sup> Claret fluorescence images (<strong>D</strong>) and intensities (<strong>E</strong>) of ID8 tumor-bearing normal and DIO mice at different time intervals after intravenous injection of CellVue<sup>Â®</sup> Claret-labeled PLD at the DOX dosage of 80 <em>Âµ</em>g per mouse. Data are presented as meansâ€‰Â±â€‰SD (<em>n</em>â€‰=â€‰3). <strong>F</strong>Â DOX contents in tumor tissues of ID8 tumor-bearing normal or DIO mice at 24Â h after intravenous injection of PLD at the DOX dosage of 80 <em>Âµ</em>g per mouse. Data are presented as meansâ€‰Â±â€‰SD (<em>n</em>â€‰=â€‰5). <strong>G</strong>-<strong>M</strong>Â Numbers of CD11c<sup>+</sup>CD80<sup>+</sup>CD86<sup>+</sup> (<strong>G</strong>), CD8<sup>+</sup> T (H), CD8<sup>+</sup>CD69<sup>+</sup> T (<strong>I</strong>), CD8<sup>+</sup>Ki67<sup>+</sup> T (<strong>J</strong>), CD8<sup>+</sup>IL-2<sup>+</sup> T (<strong>K</strong>), CD8<sup>+</sup>IFN-<em>Î³</em><sup>+</sup> T (<strong>L</strong>) and CD8<sup>+</sup>GzmB<sup>+</sup> T (<strong>M</strong>) cells in tumor tissues of ID8 tumor-bearing mice at 13 days after treatments indicated in (A). Data are presented as meansâ€‰Â±â€‰SD (<em>n</em>â€‰=â€‰6 mice in each group). *<em>P</em>â€‰&lt;â€‰0.05, **<em>P</em>â€‰&lt;â€‰0.01, ***<em>P</em>â€‰&lt;â€‰0.001</p></figcaption></figure><p id="Par44">To determine the potential mechanism by which obesity enhanced the therapeutic efficacy of PLD in ovarian cancer, we first assessed the in vivo biodistribution of PLD in normal and DIO mice bearing ID8 ovarian tumors by intravenously injecting CellVue<sup>Â®</sup> Claret-labeled PLD. Whole-animal fluorescence imaging analyses demonstrated a significant increase in CellVue<sup>Â®</sup> Claret fluorescence intensity in tumor tissues of the DIO mice compared to normal mice (Fig.Â <a href="#Fig1" class="usa-link">1</a>D and E). Whole-animal fluorescence imaging analyses showed a significant increase in CellVue<sup>Â®</sup> Claret fluorescence intensity in tumor tissues of DIO mice compared to normal mice (Fig.Â <a href="#Fig1" class="usa-link">1</a>D and E). Ex vivo imaging of tumor tissues 24Â h after intravenous injection further revealed the enhanced accumulation of PLD in tumors of DIO mice (Fig. S6A and B). To further confirm the enhanced tumor accumulation of PLD in obese mice, PLD at a DOX dosage of 80 <em>Âµ</em>g per mouse were intravenously injected. 24Â h after injection, the DOX content in major organs, including hearts, livers, spleens, lungs, kidneys and tumor tissues, was quantified using high-performance liquid chromatography (HPLC). PLD accumulation in tumor tissues of DIO mice was approximately 3.5-fold higher than in normal mice, although no significant difference was detected in other tissues (Fig.Â <a href="#Fig1" class="usa-link">1</a>E), suggesting that obesity may facilitate the delivery of PLD to ovarian tumors. Additionally, the tumor immune microenvironment was assessed in normal and DIO mice bearing ID8 tumors following intravenous injection of PLD bi-daily for a total of 3 times. Consistently, PLD treatment significantly increased the number of mature DCs, identified as CD11c<sup>+</sup>CD80<sup>+</sup>CD86<sup>+</sup>, in tumors of DIO mice compared with that of normal mice (Fig.Â <a href="#Fig1" class="usa-link">1</a>G), revealing that PLD efficiently promoted intratumoral DC maturation in DIO mice. Moreover, the DIO group exhibited a significant upregulation in the numbers of CD8<sup>+</sup> T cells (Fig.Â <a href="#Fig1" class="usa-link">1</a>H), as well as functional CD8<sup>+</sup>CD69<sup>+</sup> T cells (Fig.Â <a href="#Fig1" class="usa-link">1</a>I) and proliferating CD8<sup>+</sup>Ki67<sup>+</sup> T cells (Fig.Â <a href="#Fig1" class="usa-link">1</a>J) in tumors after PLD treatment. Meanwhile, the highest percentages of CD8<sup>+</sup> T cells expressing key effector molecules, including interleukin (IL)âˆ’2 (Fig.Â <a href="#Fig1" class="usa-link">1</a>K) which promotes T cell proliferation and differentiation, interferon (IFN)-<em>Î³</em> (Fig.Â <a href="#Fig1" class="usa-link">1</a>L) which enhances antigen presentation and T cell activation; and granzyme B (GzmB) (Fig.Â <a href="#Fig1" class="usa-link">1</a>M) which directly induces tumor cell apoptosis, were observed in PLD-treated DIO mice [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. Altogether, these results indicated that obesity can alter the tumor immune microenvironment in response to chemotherapy, leading to an enhanced therapeutic response to chemotherapy.</p></section><section id="Sec4"><h3 class="pmc_sec_title">Protein corona may be the key factor in regulating PLD efficacy in DIO mice</h3>
<p id="Par45">Protein corona significantly influences the in vivo transport processing of nanoparticles, thereby affecting their biological function. Given that PLD had different anticancer effects when administered to normal and DIO mice, it promotes our hypothesis that distinct protein coronas formed around PLD might modulate its in vivo behavior. To test this, we generated PLD with adsorbed protein coronas by incubating PLD with plasma from normal or DIO mice in vitro (denoted as PLD@NP and PLD@DP, respectively). Dynamic light scattering (DLS) analysis revealed that both PLD@NP and PLD@DP exhibited a significant increase in diameter (Fig.Â <a href="#Fig2" class="usa-link">2</a>A) and a shift in zeta potential from nearly neutral to negatively charged (Fig.Â <a href="#Fig2" class="usa-link">2</a>B) compared to PLD alone, indicating successful adsorption of plasma proteins onto PLD, a phenomenon also confirmed in other studies [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>, <a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>]. However, the diameter and zeta potential of PLD@NP and PLD@DP were comparable (Fig.Â <a href="#Fig2" class="usa-link">2</a>A and B). Although PLD@NP and PLD@DP adsorbed the same amount of plasma proteins, the specific plasma protein species adsorbed onto their surfaces were significantly different, as demonstrated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (Fig.Â <a href="#Fig2" class="usa-link">2</a>C). Additionally, we recovered and isolated PLD directly from the plasma of normal and DIO mice that had undergone intravenous PLD administration to obtain PLD@NP and PLD@DP. Consistently, PLD@NP and PLD@DP obtained in vivo showed similar diameter (Fig. S7A), zeta potential (Fig. S7B) and protein contents (Fig. S7C), but displayed different protein profiles (Fig. S7D). These findings indicated that the protein corona might be involved in regulating the efficacy of chemotherapy and the tumor microenvironment in DIO mice.</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372299_12951_2025_3635_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a62/12372299/b4a6872d0319/12951_2025_3635_Fig2_HTML.jpg" loading="lazy" id="MO4" height="595" width="669" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>In vitro antitumor immunity induced by PLD@DP. <strong>A</strong>, <strong>B</strong> The diameter (<strong>A</strong>) and zeta potential (<strong>B</strong>) of PLD after preincubation with normal or DIO mice plasma. Data are presented as meansâ€‰Â±â€‰SD (<em>n</em>â€‰=â€‰3). <strong>C</strong>Â Representative silver-stained SDS-PAGE of PLD@NP and PLD@DP. <strong>D</strong>Â DOX mean fluorescence intensity (MFI) in ID8 cells after treatment with PLD@NP or PLD@DP at the DOX concentration of 10 <em>Âµ</em>g mL<sup>âˆ’1</sup> at 37Â Â°C for 4Â h by flow cytometry. Data are presented as meansâ€‰Â±â€‰SD (<em>n</em>â€‰=â€‰3). <strong>E</strong>Â Cell viability of ID8 cells at 24Â h after treatment with PLD@NP or PLD@DP at DOX concentration of 10 <em>Âµ</em>g mL<sup>âˆ’1</sup>. Data are presented as meansâ€‰Â±â€‰SD (<em>n</em>â€‰=â€‰5). <strong>F</strong> CRT MFI in ID8 cells at 12Â h after treatments indicated in (<strong>E</strong>) by flow cytometry. Data are presented as meansâ€‰Â±â€‰SD (<em>n</em>â€‰=â€‰4). (G, H) ATP (G) and HMGB1 release (H) from ID8 cells at 12Â h after treatments indicated in (<strong>E</strong>). Data are presented as meansâ€‰Â±â€‰SD (<em>n</em>â€‰=â€‰4). (<strong>I</strong>) Percentages of CD80<sup>+</sup>CD86<sup>+</sup> cells in CD11c<sup>+</sup> BMDCs at 12Â h after immature BMDCs were co-cultured with ID8 cells treated as indicated in (<strong>E</strong>) by flow cytometry. Data are presented as meansâ€‰Â±â€‰SD (<em>n</em>â€‰=â€‰4). (<strong>J</strong>-<strong>L</strong>) Percentages of IL-2<sup>+</sup> (<strong>J</strong>), GzmB<sup>+</sup> (<strong>K</strong>) and IFN-<em>Î³</em><sup>+</sup> (<strong>L</strong>) cells in CD8<sup>+</sup> T cells after CD3<sup>+</sup> T cells were incubated with the matured BMDCs treated as indicated in (<strong>I</strong>) for 3 days by flow cytometry. Data are presented as meansâ€‰Â±â€‰SD (<em>n</em>â€‰=â€‰4). *<em>P</em>â€‰&lt;â€‰0.05, **<em>P</em>â€‰&lt;â€‰0.01, ***<em>P</em>â€‰&lt;â€‰0.001</p></figcaption></figure><p id="Par47">To ascertain the role of protein corona in the modulation of antitumor efficacy of PLD, ID8 cells were first treated with PLD@NP or PLD@DP at 37Â Â°C for 4Â h, after which intracellular DOX fluorescence was measured using flow cytometry. Expectedly, PLD@DP demonstrated greater internalization into ID8 cells than PLD@NP (Fig.Â <a href="#Fig2" class="usa-link">2</a>D and Fig. S8). Accordingly, PLD@DP exhibited stronger cytotoxicity against ID8 cells compared to PLD@NP (Fig.Â <a href="#Fig2" class="usa-link">2</a>E). Consistently, PLD@DP treatment resulted in enhanced exposure of calreticulin (CRT) (Fig.Â <a href="#Fig2" class="usa-link">2</a>F) and increased release of adenosine triphosphate (ATP) (Fig.Â <a href="#Fig2" class="usa-link">2</a>G) and high mobility group box 1 (HMGB1) (Fig.Â <a href="#Fig2" class="usa-link">2</a>H) in ID8 cells compared to PLD@NP, suggesting that PLD@DP induced a more potent immunogenic cell death (ICD) effects in ID8 cells. When ID8 cells treated with PLD@NP or PLD@DP were co-cultured with bone marrow-derived dendritic cells (BMDCs), the PLD@DP-treated group exhibited a higher level of BMDC maturation compared to the PLD@NP-treated group (Fig.Â <a href="#Fig2" class="usa-link">2</a>I). Additionally, flow cytometric analysis demonstrated that when naÃ¯ve T cells were co-incubated with BMDCs treated with PLD@DP, there was a significant increase in the percentage of CD8<sup>+</sup> T cells producing effector molecules IL-2 (Fig.Â <a href="#Fig2" class="usa-link">2</a>J), GzmB (Fig.Â <a href="#Fig2" class="usa-link">2</a>K) and IFN-<em>Î³</em> (Fig.Â <a href="#Fig2" class="usa-link">2</a>L), indicating that BMDCs matured by tumor cells treated with PLD@DP have a stronger capacity to activate CD8<sup>+</sup> T cells. However, we noticed that PLD@NP and PLD@DP did not remarkably affect cell viability of BMDCs (Fig. S9) at the used DOX concentration, suggesting that PLD@NP and PLD@DP do not exert cytotoxicity against BMDCs. These data collectively indicated that the protein corona, particularly that derived from DIO mice, significantly influenced the antitumor activity of PLD by enhancing its internalization into tumor cells and promoting a more effective antitumor immune response.</p></section><section id="Sec5"><h3 class="pmc_sec_title">C1q is adsorbed onto PLD in DIO mice</h3>
<p id="Par48">To further investigate the specific proteins influencing the in vivo behavior of PLD, we analyzed the protein components of PLD@NP and PLD@DP using liquid chromatography-mass spectrometry (LC-MS) and referenced the Protein Data Bank. Identification of all proteins revealed that PLD@NP and PLD@DP mainly recruited proteins with smaller molecular weights (10â€“60Â kDa) (Fig.Â <a href="#Fig3" class="usa-link">3</a>A). A volcano plot was used to depict these differences (Fig.Â <a href="#Fig3" class="usa-link">3</a>B), and a Venn diagram highlighted the distinctions in adsorbed proteins between PLD@NP and PLD@DP. With a threshold of fold changeâ€‰&gt;â€‰1.2 and <em>P</em>â€‰â‰¤â€‰0.05, a total of 102 differentially expressed proteins were detected (Fig.Â <a href="#Fig3" class="usa-link">3</a>C). Gene ontology (GO) functional enrichment analysis revealed that the differential proteins adsorbed on PLD@DP were predominantly associated with human diseases and organismal systems pathways, particularly those related to the immune system (Fig.Â <a href="#Fig3" class="usa-link">3</a>D). Kyoto encyclopedia of genes and genomes (KEGG) pathway analysis of the top twenty differential protein pathways showed that the â€œcomplement and coagulation cascadesâ€ pathway had the highest number of differential proteins, indicating that PLD@DP adsorbed more complement system-related proteins than PLD@NP (Fig.Â <a href="#Fig3" class="usa-link">3</a>E). Among the complement proteins, C1q exhibited the most significant change, with a 2.4-fold increase in adsorption on PLD@DP compared to PLD@NP (Fig.Â <a href="#Fig3" class="usa-link">3</a>F). Consistently, ELISA assay confirmed higher C1q levels in the plasma of DIO mice than in normal mice (Fig. S10). At 100 <em>Âµ</em>g DOX, PLD@DP adsorbed 236 <em>Âµ</em>g of C1q protein, while PLD@NP adsorbed 189 <em>Âµ</em>g of C1q protein (Fig.Â <a href="#Fig3" class="usa-link">3</a>G), confirming a significant increase in C1q content on PLD@DP compared to PLD@NP. These findings revealed that PLD@DP-adsorbed proteins, especially C1q, might modulate the biological activity of PLD in DIO mice.</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372299_12951_2025_3635_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a62/12372299/a4c763e3c265/12951_2025_3635_Fig3_HTML.jpg" loading="lazy" id="MO5" height="1016" width="701" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Proteomic analysis of protein components on PLD@NP and PLD@DP. <strong>A</strong> Classification of proteins of PLD@NP and PLD@DP according to molecular weight. <strong>B</strong>Â Volcano plot for identifying differentially expressed proteins on PLD@NP and PLD@DP. The <em>P</em> values were adjusted using the Benjamini and Hochbergâ€™s approach for controlling the false discovery rate. <em>P</em>â€‰â‰¤â€‰0.05 and Foldchangeâ€‰&gt;â€‰1.2 were set as the thresholds for significant differential expression. (<strong>C</strong>) Number of differentially expressed proteins adsorbed by PLD@NP and PLD@DP. <strong>D</strong>Â GO enrichment analysis of immune-related biological processes among differentially expressed proteins between PLD@NP and PLD@DP. <strong>E</strong>Â KEGG pathway analysis of differentially expressed proteins between PLD@NP and PLD@DP, with the top 20 terms were selected. Statistical significance was assessed using a two-sided hypergeometric test, with <em>P</em> values adjusted for multiple comparisons using the Benjamini-Hochberg method. <strong>F</strong>Â Complement proteins with significant quantitative differences between PLD@NP and PLD@DP. <strong>G</strong>Â C1q content on PLD@NP and PLD@DP by ELISA assay. Data are presented as meansâ€‰Â±â€‰SD (<em>n</em>â€‰=â€‰3). *<em>P</em>â€‰&lt;â€‰0.05</p></figcaption></figure></section><section id="Sec6"><h3 class="pmc_sec_title">C1q is involved in the enhanced tumor cell targeting and improved antitumor immunity of PLD in DIO mice</h3>
<p id="Par50">C1q, a hexameric molecule consisting of a spherical head (gC1q) and a collagenous tail (cC1q), binds to two distinct receptors, gC1qR and CRT (Fig.Â <a href="#Fig4" class="usa-link">4</a>A), respectively [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>]. gC1qR is highly expressed on tumor cells [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>]. To determine if C1q on PLD enhanced tumor targeting by binding to gC1qR on tumor cells of DIO mice, we created ID8 cells with stable gC1qR knockdown (ID8<sup>KO</sup> cells) using the CRISPR/Cas9 system (Fig.Â <a href="#Fig4" class="usa-link">4</a>B and Fig. S11). DIO mice were implanted with ID8 or ID8<sup>KO</sup> cells subcutaneously and then treated with PLD <em>via</em> tail vein injection. Tumor accumulation of PLD was assessed 24Â h post-injection. As expected, knocking down gC1qR significantly reduced PLD accumulation in tumors of DIO mice (Fig.Â <a href="#Fig4" class="usa-link">4</a>C), highlighting C1qâ€™s role in obesity-mediated tumor targeting of PLD.</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372299_12951_2025_3635_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a62/12372299/3f45ef6f52f6/12951_2025_3635_Fig4_HTML.jpg" loading="lazy" id="MO6" height="774" width="669" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Role of C1q in enhancing tumor cell targeting and improving ICD effects induced by PLD. <strong>A</strong>Â Structure of C1q. C1q consists of a spherical head (gC1q) and a collagenous tail (cC1q) that binds to two different receptors (gC1qR and CRT). <strong>B</strong>Â gC1qR expression in ID8, ID8<sup>vector</sup> (ID8 cells stably expressing empty vector) and ID8<sup>KO</sup> cells by western blotting analysis. <strong>C</strong>Â DOX contents in tumor tissues of ID8 or ID8<sup>KO</sup> tumor-bearing DIO mice at 24Â h after intravenous injection of PLD at the DOX dosage of 80 <em>Âµ</em>g per mouse. Data are presented as meansâ€‰Â±â€‰SD (<em>n</em>â€‰=â€‰4). <strong>D</strong>Â DOX MFI in ID8 or ID8<sup>KO</sup> cells after treatment with PLD@NP or PLD@DP at 37Â Â°C for 4Â h by flow cytometry. Data are presented as meansâ€‰Â±â€‰SD (<em>n</em>â€‰=â€‰3). <strong>E</strong>Â Cell viability of ID8 or ID8<sup>KO</sup> cells at 24Â h after treatment with PLD@NP or PLD@DP. Data are presented as meansâ€‰Â±â€‰SD (<em>n</em>â€‰=â€‰5). <strong>F</strong>Â CRT MFI in ID8 or ID8<sup>KO</sup> cells at 12Â h after treatments indicated in (<strong>E</strong>) by flow cytometry. Data are presented as meansâ€‰Â±â€‰SD (<em>n</em>â€‰=â€‰4). <strong>G</strong>, <strong>H</strong>Â ATP (<strong>G</strong>) and HMGB1 release (<strong>H</strong>) from ID8 or ID8<sup>KO</sup> cells at 12Â h after treatments indicated in (<strong>E</strong>). Data are presented as meansâ€‰Â±â€‰SD (<em>n</em>â€‰=â€‰4). <strong>I</strong>-<strong>K</strong>Â Intracellular DiO MFI (<strong>I</strong>), ratio of DiO<sup>+</sup> cells (<strong>J</strong>) and percentages of CD80<sup>+</sup>CD86<sup>+</sup> cells (<strong>K</strong>) in CD11c<sup>+</sup> BMDCs at 12Â h after the immature BMDCs were co-cultured with DiO-labeled ID8 or ID8<sup>KO</sup> cells pretreated as indicated in (<strong>E</strong>) by flow cytometry. Data are presented as meansâ€‰Â±â€‰SD (<em>n</em>â€‰=â€‰4). <strong>L</strong>-<strong>PÂ </strong>Percentages of CD8<sup>+</sup> T cells in CD3<sup>+</sup> T cells (<strong>L</strong>) and percentages of CD69<sup>+</sup> (<strong>M</strong>), IL-2<sup>+</sup> (<strong>N</strong>), GzmB<sup>+</sup> (<strong>O</strong>) and IFN-<em>Î³</em><sup>+</sup> (<strong>P</strong>) cells in CD8<sup>+</sup> T cells after CD3<sup>+</sup> T cells were incubated with the matured BMDCs treated as indicated in (<strong>K</strong>) for 3 days by flow cytometry. Data are presented as meansâ€‰Â±â€‰SD (<em>n</em>â€‰=â€‰4). **<em>P</em>â€‰&lt;â€‰0.01, ***<em>P</em>â€‰&lt;â€‰0.001</p></figcaption></figure><p id="Par52">To verify this, ID8 and ID8<sup>KO</sup> cells were treated with PLD@NP or PLD@DP, and then intracellular DOX content was determined. Consistently, more PLD@DP was internalized into ID8 cells than PLD@NP. The knockdown of gC1qR significantly decreased the internalization of PLD@DP, but not PLD@NP, into ID8 cells (Fig.Â <a href="#Fig4" class="usa-link">4</a>D and Fig. S12), indicating that C1q facilitated the uptake of PLD@DP by ID8 cells. Correspondingly, the knockdown of gC1qR also significantly mitigated the cytotoxicity of PLD@DP against ID8 cells (Fig.Â <a href="#Fig4" class="usa-link">4</a>E). Moreover, ID8<sup>KO</sup> cells exhibited reduced CRT exposure (Fig.Â <a href="#Fig4" class="usa-link">4</a>F) and decreased release of ATP (Fig.Â <a href="#Fig4" class="usa-link">4</a>G) and HMGB1 (Fig.Â <a href="#Fig4" class="usa-link">4</a>H) following PLD@DP treatment compared to ID8 cells, while PLD@NP treatment resulted in similar CRT exposure and HMGB1 and ATP release in both ID8 and ID8<sup>KO</sup> cells (Fig.Â <a href="#Fig4" class="usa-link">4</a>F-H), suggesting that gC1qR deletion specifically diminished ICD effects induced by PLD@DP. Furthermore, fewer PLD@DP-treated ID8<sup>KO</sup> cells were phagocytosed by BMDCs (Fig.Â <a href="#Fig4" class="usa-link">4</a>I and J), resulting in reduced maturation of BMDCs induced by PLD@DP (Fig.Â <a href="#Fig4" class="usa-link">4</a>K). Additionally, when naÃ¯ve T cells were co-cultured with these BMDCs, those matured from PLD@DP-treated ID8 cells showed significantly higher numbers of CD8<sup>+</sup> T (Fig.Â <a href="#Fig4" class="usa-link">4</a>L), CD8<sup>+</sup>CD69<sup>+</sup> T (Fig.Â <a href="#Fig4" class="usa-link">4</a>M), CD8<sup>+</sup>IL-2<sup>+</sup> T (Fig.Â <a href="#Fig4" class="usa-link">4</a>N), CD8<sup>+</sup>GzmB<sup>+</sup> T (Fig.Â <a href="#Fig4" class="usa-link">4</a>O) and CD8<sup>+</sup>IFN-<em>Î³</em><sup>+</sup> T cells (Fig.Â <a href="#Fig4" class="usa-link">4</a>P) than those from PLD@DP-treated ID8<sup>KO</sup> cells. Collectively, these results revealed that C1q significantly influenced the targeting of PLD to tumor cells, potentially modulating the antitumor immune response to exert anticancer effects induced by PLD. To further substantiate the role of C1q in regulating tumor cell targeting of PLD, we used adiponectin (ADPN), a protein containing a C1q globular head structure that can compete with C1q [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. ID8 cells were pretreated with PBS or ADPN, followed by treatment with PLD@NP or PLD@DP. Expectedly, ADPN pretreatment significantly decreased cellular uptake of PLD@DP (Fig. S13A and Fig. S14) and inhibited its cytotoxicity against ID8 cells (Fig. S13B). Additionally, ADPN pretreatment efficiently abolished PLD@DP-triggered ICD effects in ID8 cells (Fig. S13C-S13E) and the subsequent T cell-mediated antitumor immune response (Fig. S13F-S13I). In summary, the findings collectively highlight that C1q is a key regulator in directing tumor cell targeting and shaping the immune response elicited by PLD.</p></section><section id="Sec7"><h3 class="pmc_sec_title">C1q contributes to the increased phagocytosis of PLD-triggered apoptotic tumor cells to activate antitumor immunity</h3>
<p id="Par53">A hallmark of ICD is the CRT exposure on the surface of tumor cells, which serves as a receptor for cC1q [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. Immature DCs express DC-SIGN on their surface, which binds gC1q [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>]. When C1q binds to apoptotic tumor cells, C1q increases DC uptake of apoptotic tumor cells and promotes T cell-mediated anti-tumor immunity by binding to DC-SIGN [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>, <a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>]. To investigate the role of C1q in the phagocytosis of PLD-induced apoptotic cells by DCs, DiO-labeled PLD-triggered apoptotic ID8 cells were pretreated with PBS or ani-C1q antibody (denoted as Î±C1q), which specifically binds to the cC1q segment of C1q to inhibit the interaction of C1q and CRT. Subsequently, these cells were treated with PLD@NP or PLD@DP and then co-incubating with BMDCs. As anticipated, BMDCs showed increased phagocytosis of DiO-labeled apoptotic ID8 cells following exposure to PLD@DP compared to PLD@NP (Fig.Â <a href="#Fig5" class="usa-link">5</a>A and B). Pretreatment with Î±C1q significantly diminished the enhanced phagocytosis of apoptotic ID8 cells by BMDCs induced by PLD@DP (Fig.Â <a href="#Fig5" class="usa-link">5</a>A and B), while no significant changes were observed in PLD@DP-treated group. These findings suggested that the presence of C1q on PLD@DP was essential for the enhanced phagocytosis of apoptotic tumor cells by DCs. Furthermore, Î±C1q significantly reduced the maturation of BMDCs enhanced by PLD@DP (Fig.Â <a href="#Fig5" class="usa-link">5</a>C). When these BMDCs were co-cultured with splenic T cells, the PLD@DP-treated group exhibited higher frequencies of IL-2<sup>+</sup> (Fig.Â <a href="#Fig5" class="usa-link">5</a>D), GzmB<sup>+</sup> (Fig.Â <a href="#Fig5" class="usa-link">5</a>E) and IFN-<em>Î³</em><sup>+</sup> cells (Fig.Â <a href="#Fig5" class="usa-link">5</a>F) within CD8<sup>+</sup> T cells compared to PLD@NP-treated group. In contrast, Î±C1q significantly decreased PLD@DP-triggered CD8<sup>+</sup> T cell activation (Fig.Â <a href="#Fig5" class="usa-link">5</a>D-F). Collectively, these results indicated that C1q on PLD@DP contributed to the phagocytosis of PLD-induced apoptotic tumor cells by DCs, leading to increased DC maturation and CD8<sup>+</sup> T cell activation.</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372299_12951_2025_3635_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a62/12372299/c6ada123650d/12951_2025_3635_Fig5_HTML.jpg" loading="lazy" id="MO7" height="525" width="669" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Role of C1q on PLD@DP in increasing phagocytosis of apoptotic cells by DCs. <strong>A</strong>, <strong>B</strong> Intracellular DiO MFI (<strong>A</strong>) and ratio of DiO<sup>+</sup> cells (<strong>B</strong>) in CD11c<sup>+</sup> BMDCs at 12Â h after the immature BMDCs were co-cultured with DiO-labeled ID8 cells which were pretreated with PBS or Î±C1q (2 <em>Âµ</em>g mL<sup>âˆ’1</sup>)for 1Â h and then treated with PLD@NP or PLD@DP at the DOX concentration of 10 <em>Âµ</em>g mL<sup>âˆ’1</sup> for 24Â h by flow cytometry. Data are presented as meansâ€‰Â±â€‰SD (<em>n</em>â€‰=â€‰4). <strong>C</strong>Â Percentages of CD80<sup>+</sup>CD86<sup>+</sup> cells in CD11c<sup>+</sup> BMDCs at 12Â h after immature BMDCs were co-cultured with ID8 cells treated as indicated in (A) by flow cytometry. Data are presented as meansâ€‰Â±â€‰SD (<em>n</em>â€‰=â€‰4). <strong>D</strong>-<strong>F</strong>Â Percentages of IL-2<sup>+</sup> (<strong>D</strong>), GzmB<sup>+</sup> (<strong>E</strong>) and IFN-<em>Î³</em><sup>+</sup> (<strong>F</strong>) cells in CD8<sup>+</sup> T cells after CD3<sup>+</sup> T cells were incubated with the matured BMDCs treated as indicated in (<strong>C</strong>) for 3 days by flow cytometry. Data are presented as meansâ€‰Â±â€‰SD (<em>n</em>â€‰=â€‰4). ***<em>P</em>â€‰&lt;â€‰0.001</p></figcaption></figure></section><section id="Sec8"><h3 class="pmc_sec_title">C1q significantly enhances the antitumor effects of PLD in DIO mice</h3>
<p id="Par55">To delve deeper into how C1q influences the antitumor effects and immune reactions triggered by PLD in obese mice, DIO mice that had either subcutaneous ID8 tumors or ID8<sup>KO</sup> tumors were were subjected to treatments with PBS or PLD in the presence or absence of Î±C1q (Fig.Â <a href="#Fig6" class="usa-link">6</a>A). Consistently, PLD significantly slowed the growth of ID8 tumors compared to PBS (Fig.Â <a href="#Fig6" class="usa-link">6</a>B), resulting in a higher tumor suppression rate (Fig.Â <a href="#Fig6" class="usa-link">6</a>C), reduced tumor weight (Fig.Â <a href="#Fig6" class="usa-link">6</a>D) and extended survival time (Fig.Â <a href="#Fig6" class="usa-link">6</a>E). Both knocking down gC1qR in ID8 tumors and treatment with Î±C1q significantly reduced the antitumor effects of PLD (Fig.Â <a href="#Fig6" class="usa-link">6</a>B-E), suggesting that the regulation of PLDâ€™s antitumor efficacy was significantly influenced by C1q in DIO mice. Moreover, knocking down gC1qR in ID8 tumors or treatment with Î±C1q markedly reduced PLD-induced increase in the numbers of CD11c<sup>+</sup>CD80<sup>+</sup>CD86<sup>+</sup> DCs (Fig.Â <a href="#Fig6" class="usa-link">6</a>F), CD8<sup>+</sup> T cells (Fig.Â <a href="#Fig6" class="usa-link">6</a>G), proliferating CD8<sup>+</sup>Ki67<sup>+</sup> T cells (Fig.Â <a href="#Fig6" class="usa-link">6</a>H), and activated CD8<sup>+</sup>CD69<sup>+</sup> T cells (Fig.Â <a href="#Fig6" class="usa-link">6</a>I), as well as CD8<sup>+</sup>IL-2<sup>+</sup> T (Fig.Â <a href="#Fig6" class="usa-link">6</a>J), CD8<sup>+</sup>IFN-<em>Î³</em><sup>+</sup> T (Fig.Â <a href="#Fig6" class="usa-link">6</a>K) and CD8<sup>+</sup>GzmB<sup>+</sup> T cells (Fig.Â <a href="#Fig6" class="usa-link">6</a>L), indicating that C1q participated in the antitumor immune response triggered by PLD in DIO mice. Notably, treatment with Î±C1q further decreased PLD-induced antitumor activity and antitumor immunity in DIO mice bearing ID8<sup>KO</sup> tumors (Fig.Â <a href="#Fig6" class="usa-link">6</a>B-L), indicating that PLD-triggered enhanced antitumor activity and improved antitumor immunity were regulated by C1q, which contributed to increased tumor accumulation of PLD and promoted the phagocytosis of PLD-induced apoptotic tumor cells by DCs for improved antitumor immunity.</p>
<figure class="fig xbox font-sm" id="Fig6"><h4 class="obj_head">Fig. 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372299_12951_2025_3635_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a62/12372299/d579a40a221b/12951_2025_3635_Fig6_HTML.jpg" loading="lazy" id="MO8" height="1015" width="707" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>PLD-induced anticancer activity and enhanced antitumor immunity in a C1q-dependent manner in DIO mice. <strong>A</strong> Schematic timeline for anticancer activity and tumor immune microenvironment analysis in ID8 or ID8<sup>KO</sup> tumor-bearing DIO mice after intravenous administration of three doses of PLD at the DOX dosage of 4Â mg kg<sup>âˆ’1</sup> once every other day with or without of intratumoral administration of Î±C1q antibody at the dosage of 150 <em>Âµ</em>g 24Â h after PLD injection. <strong>B</strong>Â Tumor volume curves of ID8 or ID8<sup>KO</sup> tumor-bearing DIO mice after treatments indicated in (<strong>A</strong>), respectively. Data are presented as meansâ€‰Â±â€‰SD (<em>n</em>â€‰=â€‰7). <strong>C</strong>, <strong>D</strong>Â Tumor suppression rate (<strong>C</strong>) and tumor weight (<strong>D</strong>) at day 13 after treatments indicated in (<strong>A</strong>). Data are presented as meansâ€‰Â±â€‰SD (<em>n</em>â€‰=â€‰7). (<strong>E)</strong> Kaplanâ€“Meier survival plots of ID8 or ID8<sup>KO</sup> tumor-bearing DIO mice after treatments indicated in (<strong>A</strong>). Data are presented as meansâ€‰Â±â€‰SD (<em>n</em>â€‰=â€‰8). (<strong>F-L</strong>) Numbers of CD11c<sup>+</sup>CD80<sup>+</sup>CD86<sup>+</sup> (<strong>F</strong>), CD8<sup>+</sup> T (<strong>G</strong>), CD8<sup>+</sup>Ki67<sup>+</sup> T (<strong>H</strong>), CD8<sup>+</sup>CD69<sup>+</sup> T (<strong>I</strong>), CD8<sup>+</sup>IL-2<sup>+</sup> T (<strong>J</strong>), CD8<sup>+</sup>IFN-<em>Î³</em><sup>+</sup> T (<strong>K</strong>) and CD8<sup>+</sup>GzmB<sup>+</sup> T (<strong>L</strong>) cells in tumor tissues of ID8 or ID8<sup>KO</sup> tumor-bearing DIO mice at 13 days after treatments indicated in (<strong>A</strong>). Data are presented as meansâ€‰Â±â€‰SD (<em>n</em>â€‰=â€‰7). *<em>P</em>â€‰&lt;â€‰0.05, **<em>P</em>â€‰&lt;â€‰0.01, ***<em>P</em>â€‰&lt;â€‰0.001 </p></figcaption></figure></section></section><section id="Sec9"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par57">The relationship between obesity and cancer outcomes has been a subject of intense debate, with recent clinical data suggesting a paradoxical association between obesity and improved cancer therapeutic outcomes. Ovarian cancer patients with higher BMIs have shown improved progression-free survival after chemotherapy treatments, including PLD [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. Similar trends have been noted in diffuse large B-cell lymphoma [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>] and melanoma patients [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>] undergoing chemotherapy or immunotherapy. As obesity rates continue to rise globally, it is imperative to investigate the mechanisms by which obesity influences chemotherapy and to develop targeted therapies for cancer patients.</p>
<p id="Par58">The formation of the protein corona significantly influences the properties of nanomedicines. Strategies to design and manipulate the protein corona can be categorized into two main approaches. The first involves minimizing protein corona formation by employing the â€œstealth effect,â€ where a hydrophilic polymer such as PEG is used to coat nanomedicines, reducing non-specific interactions with blood proteins and enhancing circulation times [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>, <a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>]. The second strategy involves intentionally adsorbing specific plasma proteins to enhance the targeting efficiency of nanomedicines through surface engineering [<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>, <a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>]. However, the range of adsorbed proteins is currently limited, with few studies exploring the roles of proteins beyond the apolipoprotein family and albumin in the in vivo behavior of nanomedicines. In this study, we uncovered that the chronic inflammatory environment associated with obesity led to the upregulation of C1q protein in mouse plasma, which adsorbed to PLD with high affinity. The interaction between C1q and gC1qR on tumor cells not only conferred tumor-targeting capabilities to PLD but also amplified the ICD effects, leading to significant tumor suppression in DIO mice.</p>
<p id="Par59">The ICD phenomenon allows DCs to recognize and eliminate apoptotic tumor cells through â€œeat meâ€ signals such as CRT, thereby promoting T cell-mediated antitumor immunity [<a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>]. However, a delay in the quick removal of apoptotic cells can result in their disintegration and the release of immunogenic molecules like TNF-Î± into the surrounding tissue, triggering a pro-inflammatory response and potentially leading to autoimmunity [<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>, <a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>]. Previous works have indicated that certain collagen family members, including the complement protein C1q, serve as co-stimulatory molecules that expedite the clearance of apoptotic cells by DCs, preventing the release of inflammatory factors [<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>]. Additionally, Andrea et al. demonstrated that C1q bound to apoptotic cells inhibited the proliferation of Th17 and Th1 T cell subsets mediated by macrophages and DCs, thereby remodeling the adaptive immune system [<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>]. This highlights the dual role of C1q in promoting the clearance of apoptotic cells by phagocytes and in regulating inflammatory responses within the autophagic system. In this work, we discovered that C1q adsorbed onto PLD not only intensified the ICD effects but also engaged in the phagocytosis of apoptotic tumor cells by DCs, which promoted antitumor immunity to exert strong anticancer efficacy in DIO mice. However, the exact mechanism by which C1q on PLD promoted DC phagocytosis of apoptotic tumor cells required further clarification. In addition, C1q serves a critical role in the classical complement pathway, recognizing and contributing to the lysis of tumor cells [<a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>]. The extent to which C1q influenced complement-dependent cytotoxic effects in the anticancer activity of PLD in DIO mice warranted additional investigation.</p></section><section id="Sec10"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par60">In summary, our study reveals that PLD in obese mice adsorbs a higher quantity of C1q protein, which effectively targets tumor cells and induces greater ICD effects. The binding of C1q to apoptotic tumor cells facilitates DC phagocytosis, enhancing the antigen-presenting capacity of DCs and activating CD8<sup>+</sup> T cells. This C1q-mediated process significantly promotes the efficacy of PLD in cancer therapy in DIO mice. Collectively, this strategy highlights the importance of the personalized protein corona in regulating the therapeutic efficacy of nanomedicines, offering innovative avenues for the personalized treatment of cancer patients.</p></section><section id="Sec11"><h2 class="pmc_sec_title">Methods and experimental</h2>
<section id="Sec12"><h3 class="pmc_sec_title">Materials</h3>
<p id="Par61">RPMI 1640 and DMEM medium were purchased from HyClone (GE Healthcare, South Logan, USA). Phosphate-buffered saline (PBS) were purchased from Servicebio (Wuhan, China). Trypsin EDTA, fetal bovine serum (FBS), penicillin and streptomycin were provided by Vazyme Biotech Co., Ltd (Wuhan, China). Recombinant Adiponectin (ADPN) protein (RP01461) was purchased from ABclonal Biotechnology Co., Ltd. (Wuhan, China). Anti-C1q antibody (JL-1, ab71940) was purchased from Abcam Company (Cambridge, UK). C1q ELISA kit was purchased from Fengbin Technology Co., Ltd. (Wuhan, China). CellVue<sup>Â®</sup> Claret kit was purchased from Merck (Darmstadt, German). 10Â kcal% normal-fat diet (AIN-93G) and 60Â kcal% high-fat diet (D12492i) were purchased from Jiangsu Xietong, Inc. (Nanjing, China) and Shanghai Renbang Pharmaceutical Technology Co., Ltd., respectively. PLD was obtained from CSPC Ouyi Pharmaceutical CO., Ltd. (Shijiazhuang, China). The size and zeta potential of PLD was determined by DLS analysis. The morphology of PLD was observed by TEM (Tecnai G2 20; FEI) with an accelerating voltage of 60Â kV.</p></section><section id="Sec13"><h3 class="pmc_sec_title">Cell culture</h3>
<p id="Par62">ID8 cells were obtained from Shanghai Hongshun Biological Technology Co. Ltd (Shanghai, China). The cells were maintained in DMEM medium enriched with 10% FBS and 100 <em>Âµ</em>g mL<sup>âˆ’1</sup> penicillin-streptomycin. The culture was incubated at 37Â Â°C in an environment with 5% CO<sub>2</sub>. BMDCs were extracted from femurs and tibiae of female C57BL/6 mice aged 8 weeks and maintained in RPMI 1640 medium enriched with 10% FBS, 100 <em>Âµ</em>g mL<sup>âˆ’1</sup> penicillin-streptomycin, 10 ng mL<sup>âˆ’1</sup> recombinant mouse granulocyte-macrophage colony-stimulating factor (GM-CSF, PeproTech, Rocky Hill, USA) and 10 ng mL<sup>âˆ’1</sup> IL-4 (PeproTech). CD3<sup>+</sup> T cells were purified from the splenocytes of female C57BL/6 mic aged 8 weeks using a MokoSortâ„¢ Mouse CD3<sup>+</sup> T cell isolation kit (Biolegend, San Diego, USA) and expanded in RPMI 1640 medium containing 10% FBS, 100 <em>Âµ</em>g mL<sup>âˆ’1</sup> penicillin-streptomycin and 20 ng mL<sup>âˆ’1</sup> IL-2 (PeproTech) for 5 days. Regular mycoplasma testing was conducted on all cell cultures using the MycAway-Color detection kit (Yeasen Biotechnology Co., Ltd, Shanghai, China) to confirm their mycoplasma-free status.</p></section><section id="Sec14"><h3 class="pmc_sec_title">Animals</h3>
<p id="Par63">Four-week-old female C57BL/6 mice (12â€‰Â±â€‰2Â g) were procured from Beijing Vital River Laboratory Animal Technology Co., Ltd. (Beijing, China). These mice were used to establish a subcutaneous ID8 ovarian tumor model by inoculating 5â€‰Ã—â€‰10<sup>6</sup> ID8 cells into the left lower flank region. All animal studies conducted complied with ethical standards for animal research, and were approved by the Institutional Animal Care and Use Committee at Tongji Medical College, Huazhong University of Science and Technology (Wuhan, China).</p></section><section id="Sec15"><h3 class="pmc_sec_title">Construction of obesity models</h3>
<p id="Par64">week-old female C57BL/6 were randomly separated into normal and DIO group. The normal group and DIO group were constructed in the same living conditions except that normal mice were maintained on a normal-fat diet, while DIO mice were provided with a high-fat diet. The mouse weight was detected weekly using an electronic balance. After 13 weeks of continuous feeding, the blood was collected by removing the eyeballs and then centrifuged at 3,000<em>g</em> for 10Â min to obtain mouse serum. The contents of glucose, cholesterol, HDL-C and LDL-C in the mouse serum were measured with automatic biochemical analyzer (Beckman, Pasadena, USA). After the mice were executed, the body length was evaluated and their gonads and inguinal fat were dissected. The Leeâ€™s index was calculated according to the following formulation</p>
<table class="disp-formula p" id="Equa"><tr><td class="formula"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a62/12372299/acbc06136b1b/d33e1889.gif" loading="lazy" id="d33e1889" alt="graphic file with name d33e1889.gif"></td></tr></table></section><section id="Sec16"><h3 class="pmc_sec_title">Characterization of PLD@NP and PLD@D</h3>
<p id="Par66">PLD at the DOX concentration of 2Â mg mL<sup>âˆ’1</sup> (100 <em>Âµ</em>L) was incubated with 100 <em>Âµ</em>L normal mouse plasma or DIO mouse plasma for 1Â h at 37Â Â°C on a homogeneous shaker. The mixtures were centrifuged at 100,000<em>g</em> for 30Â min to pellet PLD@NP and PLD@DP, followed by washing with cold PBS. Furthermore, 100 <em>Âµ</em>L of PLD was intravenously injected into normal or DIO mice at the DOX dosage of 80 <em>Âµ</em>g per mouse. After 2Â h, mouse plasma was collected by removing mouse eyeballs, and then centrifuged at 500<em>g</em> for 5Â min and 100,000<em>g</em> for 30Â min to isolate PLD@NP and PLD@DP, which were rinsed three times with PBS. The diameter and zeta potential of PLD@NP and PLD@DP were measured employing a Malvern Nano-ZS Particle Sizer (Malvern Instruments Ltd., Malvern, UK). The DOX and protein contents in PLD@NP and PLD@DP were quantified by HPLC and the BCA protein assay kit (Beyotime, Shanghai, China), respectively. The protein profiles of PLD@NP and PLD@DP were examined through SDS-PAGE and further chromatographed by using the rapid silver stain kit (Beyotime, Shanghai, China).</p></section><section id="Sec17"><h3 class="pmc_sec_title">Proteomics analysis</h3>
<p id="Par67">Proteins from PLD@NP and PLD@DP were extracted and assessed for quality control using the Bradford quantification assay and SDS-PAGE. The proteins were then digested with trypsin to generate peptides, which were labeled using the iTRAQ Reagent-8PLEX Multiplex Kit (Applied Biosystems Sciex, Carlsbad, USA). Specifically, peptides from PLD@NP were labeled with 118-, 119-, and 121-tags, while peptides from PLD@DP were labeled with 115-, 116-, and 117-tags. Liquid chromatographic separation was carried out using a Shimadzu LC-20AD system and a Thermo UltiMate 3000 UHPLC. Following separation, peptides were ionized by nanoESI and introduced into a Q-Exactive HF X tandem mass spectrometer (Thermo Fisher Scientific, San Jose, USA) for detection in DDA mode. Raw mass spectrometry data were converted to mgf format and analyzed using the Mascot protein identification software against relevant databases. Protein identification was performed with iQuant software (Beijing Genomics Institute, Beijing, China), and proteins identified by at least two unique peptides were considered for quantification analysis with a false discovery rate of less than 0.01.</p></section><section id="Sec18"><h3 class="pmc_sec_title">Stable knockdown of gC1qR in ID8 cells</h3>
<p id="Par68">To achieve stable knockdown of gC1qR in ID8 cells, ID8 cells were transfected with a lentivirus that contained CRISPR/Cas9 components. The lentivirus was produced by transfecting HEK 293â€‰T cells with the lentiCRISPR v2 vector (Addgene plasmid 52961), the envelope plasmid pMD2.G (Addgene plasmid 12259) and the packaging plasmid psPAX2 (Addgene plasmid 12260) in a ratio of 4:1:3. Two guide RNA sequences were used to target gC1qR: sgRNA1 with sense sequence CACCGGCGCAGCAGAGGCAGCATCG and antisense sequence AAACCGATGCTGCCTCTGCTGCGCC, sgRNA2 with sense sequence CACCGGCGTGCGCGCAGGTTCCGAG and antisense sequence AAACCTCGGAACCTGCGCGCACGCC, which were cloned into the lentiCRISPR v2 vector. Lentiviral particles were isolated 48Â h after transfection and further infected ID8 cells. ID8 cells were cultured and selected with medium containing 2 <em>Âµ</em>g mL<sup>âˆ’1</sup> puromycin for 7 days, and then expanded in DMEM medium containing 1 <em>Âµ</em>g mL<sup>âˆ’1</sup> puromycin. The efficiency of gC1qR knockdown in ID8 cells was verified via western blot. The following primary antibodies were used: mouse anti-<em>Î²</em>-actin (Proteintech, cat. No 60008-1-1Â g, clone 7D2C10, 1/2000 dilution) and anti-gC1qR (ABclonal, cat. No A11292, clone ARC2753, 1/1000 dilution).</p></section><section id="Sec19"><h3 class="pmc_sec_title">Cellular uptake by tumor cells</h3>
<p id="Par69">ID8 and ID8<sup>KO</sup> cells were exposed to PLD@NP or PLD@DP under conditions where the concentration of DOX was 10 <em>Âµ</em>g mL<sup>âˆ’1</sup>, the pH was maintained at 7.4, and the temperature was kept at 37Â Â°C for a duration of 4Â h. The cells were harvested, rinsed with PBS, and then DOX fluorescence was measured by CytoFLEX S flow cytometry (Beckman Coulter, Fullerton, USA).</p></section><section id="Sec20"><h3 class="pmc_sec_title">In vitro cytotoxic effects on cancer cells</h3>
<p id="Par70">ID8 and ID8<sup>KO</sup> cells were treated with PLD@NP or PLD@DP under conditions where the concentration of DOX was 10 <em>Âµ</em>g mL<sup>âˆ’1</sup>, the pH was maintained at 7.4, and the temperature was kept at 37Â Â°C for a duration of 24Â h. After removing the drug and washing with PBS, 10 <em>Âµ</em>L CCK-8 (Biosharp Company, Shanghai, China) was added to each well and incubated at 37Â Â°C for 2Â h in the dark. The adsorbance at 450Â nm was measured on a Labsystems iEMS microplate reader (Helsinki, Finland).</p></section><section id="Sec21"><h3 class="pmc_sec_title">In vitro assay for ICD, BMDC maturation and T cell activation</h3>
<p id="Par71">ID8 and ID8<sup>KO</sup> cells were incubated with DOX, PLD@NP or PLD@DP at DOX concentration of 10 <em>Âµ</em>g mL<sup>âˆ’1</sup> for 12Â h. The supernatants were collected for analysis of HMGB1 and ATP levels using the HMGB1 ELISA kit (Moshake Biotechnology Co., Ltd, Wuhan, China) and enhanced ATP assay kit (Beyotime, Shanghai, China), respectively. The cells were then stained with a anti-mouse CRT antibody for 30Â min and then incubated with FITC-conjugated goat anti-mouse antibody for 60Â min. The ratio of CRT-positive cells was determined using CytoFLEX S flow cytometry. The above treated ID8 cells were stained with DiO and co-cultured with immature BMDCs for 12Â h. BMDCs were subsequently stained with fluorescence-conjugated antibodies against CD11c, CD80 and CD86. Phagocytosis of tumor cells by BMDCs (CD11c<sup>+</sup>DiO<sup>+</sup> cells) and BMDC maturation (CD11c<sup>+</sup>CD80<sup>+</sup>CD86<sup>+</sup> cells) were assessed using CytoFLEX S flow cytometry.</p>
<p id="Par72">For T lymphocyte activation analysis, BMDCs from the above treatment were co-cultured with murine CD3<sup>+</sup> T cells at a ratio of 1:4 for three days. Activated T cells were collected and surface-stained with fluorescence-conjugated antibodies against CD3 and CD8. For intracellular cytokine analysis, the cells were treated with fixation buffer (Biolegend, San Diego, USA) and permeabilizing with permeabilization wash buffer (Biolegend, San Diego, USA), and then restained with fluorescence-conjugated antibodies against IL-2, IFN-<em>Î³</em> and GzmB before flow cytometric analysis. The specific multi-color antibody combinations employed for the analysis of CRT-positive cells, BMDC maturation and T cell activation are outlined in Table <a href="#MOESM1" class="usa-link">S1</a>.</p></section><section id="Sec22"><h3 class="pmc_sec_title">In vivo biodistribution</h3>
<p id="Par73">ID8 tumor-bearing normal or DIO mice were intravenously injected with CellVue<sup>Â®</sup> Claret-labeled PLD at a dose of 80 <em>Âµ</em>g DOX. The biodistribution of CellVue<sup>Â®</sup> Claret was monitored at different time intervals using a Caliper IVIS Lumina II in vivo imaging system (PerkinElmer, Waltham, MA, USA). At 24Â h post-injection, tumor tissues were excised and examined to assess the distribution of CellVue<sup>Â®</sup> Claret within the tumor. Furthermore, mice bearing ID8 and ID8<sup>KO</sup> tumors received an intravenous injection of PLD at DOX dosage of 80 <em>Âµ</em>g per mouse. At 24Â h post-administration, tumors and key organs (heart, liver, spleen, lungs and kidneys) were obtained after euthanasia of mice. The tissues were were first disrupted in 100 <em>Âµ</em>L of PBS, followed by the addition of 200 <em>Âµ</em>L of methanol. The mixture was then incubated at 4Â Â°C for 30Â min to enhance the extraction of DOX. Subsequently, 100 <em>Âµ</em>L of the supernatant was centrifuged at 10,000<em>g</em> for 10Â min. The fluorescence of DOX was detected using the FlexStation 3 Multi-Mode Microplate Reader (Molecular Devices, Sunnyvale, USA), with excitation set at 488Â nm and emission detected at 585Â nm. A calibration curve was established by spiking tissue extracts with varying DOX concentrations, enabling the calculation of DOX content in the samples based on the standard curve.</p></section><section id="Sec23"><h3 class="pmc_sec_title">In vivo anticancer activity</h3>
<p id="Par74">Mice bearing ID8 or ID8<sup>KO</sup> tumors received intravenous administration of PLD at 4Â mg kg<sup>âˆ’1</sup> DOX dosage every three days for three times. Intratumoral injections of Î±C1q were given the day after PLD injections. The tumor size was detected daily by vernier forceps. On the indicated time intervals, part of the mice were sacrificed. Major organs (heart, liver, spleen, lungs and kidneys) were fixed in 4% paraformaldehyde and preserved for H&amp;E staining. Plasma was collected for serological analysis. The remaining mice were used for survival experiments and monitored for tumor size, and were executed when the tumors reached 1500 mm<sup>3</sup>.</p></section><section id="Sec24"><h3 class="pmc_sec_title">Analysis of tumor immune milieu</h3>
<p id="Par75">After treatment, the tumors were collected, finely minced and then digested in RPMI 1640 medium with recombinant DNaseI (100 U mL<sup>âˆ’1</sup>) and collagenase I (0.8Â mg mL<sup>âˆ’1</sup>) at 37Â Â°C for 1Â h. Subsequently, the cells were centrifuged at 300<em>g</em> for 5Â min, and then lysed with erythrocyte lysate (Biosharp, Hefei, China) for 5Â min. The cells were then rinsed with PBS and filtered through a 40 <em>Âµ</em>m filter. To analyze DCs, the cells were stained with fluorescence-labeled antibodies against CD11c, CD80 and CD86. To analyze T cells, the cells were stained with fluorescence-labeled antibodies against CD3, CD8 and CD69. To stain intracellular cytokines, the cells were treated with Fix/Perm solution (Biolegend, San Diego, USA) and re-stained with fluorescence-labeled antibodies against IL-2, IFN-<em>Î³</em> and GzmB. For Ki67 staining, the surfaced-stained cells were first treated with pre-cooled 70% ethanol for 1Â h and then stained with anti-Ki67-FITC. The cells were subjected to CytoFLEX S flow cytometric analysis. Gating strategies for flow cytometric analysis of cell types involved in this study have been presented in Fig. S15. The detailed multi-color antibody panels utilized for each specific cell type are provided in Table S1.</p></section><section id="Sec25"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par76">Experiments were conducted a minimum of three times, and results were expressed as meansâ€‰Â±â€‰SD. GraphPad Prism (version 9.0) was utilized for all statistical evaluations. Comparisons between two groups were made using unpaired two-tailed Studentâ€™s t-tests, while comparisons between multiple groups for univariate variables were assessed <em>via</em> one-way ANOVA with Tukeyâ€™s HSD post-hoc test and comparisons between multiple groups for multivariate variables were assessed <em>via</em> two-way ANOVA with Bonferroniâ€™s post-test. Significance was set at <em>P</em>â€‰&lt;â€‰0.05 for all statistical tests.</p></section></section><section id="Sec26"><h2 class="pmc_sec_title">Supplementary Information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12372299/bin/12951_2025_3635_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1.</a><sup> (4.5MB, docx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>We thank the Laboratory Animal Center for Life Science (HUST) for the mice rearing service. We thank the Research Core Facilities for Life Science (HUST) and the Analytical and Testing Center of Huazhong University of Science and Technology for related analysis.</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>EPR</dt>
<dd><p id="Par3">Enhanced permeability and retention</p></dd>
<dt>BMI</dt>
<dd><p id="Par4">Body mass index</p></dd>
<dt>DCs</dt>
<dd><p id="Par5">Dendritic cells</p></dd>
<dt>BMDCs</dt>
<dd><p id="Par6">Bone marrow-derived dendritic cells</p></dd>
<dt>PLD</dt>
<dd><p id="Par7">Pegylated liposomal doxorubicin</p></dd>
<dt>RES</dt>
<dd><p id="Par8">Reticuloendothelial system</p></dd>
<dt>DIO</dt>
<dd><p id="Par9">Diet-induced obesity</p></dd>
<dt>PLD@NP</dt>
<dd><p id="Par10">PLD preincubated with normal mouse plasma</p></dd>
<dt>PLD@DP</dt>
<dd><p id="Par11">PLD preincubated with DIO mouse plasma</p></dd>
<dt>HDL-C</dt>
<dd><p id="Par12">High-density lipoprotein cholesterol</p></dd>
<dt>LDL-C</dt>
<dd><p id="Par13">Low-density lipoprotein cholesterol</p></dd>
<dt>C1q</dt>
<dd><p id="Par14">Complement component 1q</p></dd>
<dt>Î±C1q</dt>
<dd><p id="Par15">Anti-C1q</p></dd>
<dt>ADPN</dt>
<dd><p id="Par16">Adiponectin</p></dd>
<dt>IL-2</dt>
<dd><p id="Par17">Interleukin-2</p></dd>
<dt>GM-CSF</dt>
<dd><p id="Par18">Granulocyte-macrophage colony-stimulating factor</p></dd>
<dt>IL-4</dt>
<dd><p id="Par19">Interleukin-4</p></dd>
<dt>ICD</dt>
<dd><p id="Par20">Immunogenic cell death</p></dd>
<dt>CRT</dt>
<dd><p id="Par21">Calreticulin</p></dd>
<dt>ATP</dt>
<dd><p id="Par22">Adenosine triphosphate</p></dd>
<dt>HMGB1</dt>
<dd><p id="Par23">High mobility group box 1</p></dd>
<dt>TEM</dt>
<dd><p id="Par24">Transmission electron microscopic</p></dd>
<dt>DLS</dt>
<dd><p id="Par25">Dynamic light scattering</p></dd>
<dt>LC-MS</dt>
<dd><p id="Par26">Liquid chromatography-mass spectrometry</p></dd>
<dt>SDS-PAGE</dt>
<dd><p id="Par27">Sodium dodecyl sulfate-polyacrylamide gel electrophoresis</p></dd>
<dt>HPLC</dt>
<dd><p id="Par28">High-performance liquid chromatography</p></dd>
<dt>GO</dt>
<dd><p id="Par29">Gene ontology</p></dd>
<dt>KEGG</dt>
<dd><p id="Par30">Kyoto encyclopedia of genes and genomes</p></dd>
<dt>ID8<sup>KO</sup>
</dt>
<dd><p id="Par31">Stable knockdown of gC1qR in ID8 cells</p></dd>
<dt>ID8<sup>vector</sup>
</dt>
<dd><p id="Par32">ID8 cells stably expressing empty vector</p></dd>
<dt>IFN-<em>Î³</em>
</dt>
<dd><p id="Par33">Interferon-<em>Î³</em></p></dd>
<dt>GzmB</dt>
<dd><p id="Par34">Granzyme B</p></dd>
<dt>H&amp;E</dt>
<dd><p id="Par35">Hematoxylin and eosin</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>L.G., X.Y., Q.C., and S.X. designed the project. S.X., N.B., X.S., X.Z., S.L., and H.L. performed the experiments. S.X., N.B., T.Y., Q.C., X.Y., and L.G. analyzed and interpreted the data. S.X., and L.G. wrote the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This work was supported by National Basic Research Program of China (2020YFA0710700, 2022YFA1206000, 2021YFA1201200 and 2022YFA1206100) and National Natural Science Foundation of China (82272844).</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>No datasets were generated or analysed during the current study.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par77">All animal experiments received approval from the Institutional Animal Care and Use Committee at Tongji Medical College with an approval number: 4510.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par78">All authors approved the final manuscript and the submission to this journal.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par79">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisherâ€™s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Qing Chen, Email: chenqingortho@whu.edu.cn.</p>
<p>Xiangliang Yang, Email: yangxl@mail.hust.edu.cn.</p>
<p>Lu Gan, Email: lugan@mail.hust.edu.cn.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Li G, Song Z, Ru Y, Zhang J, Luo L, Yang W, Wu H, Jin H, Bao X, Wei D, Yan Z, Qu H, Zhu Z, Xue X, Zhou G. Small-molecule nanoprodrug with high drug loading and EGFR, PI3K/AKT dual-inhibiting properties for bladder cancer treatment. Exploration. 2023;3:20220141.
</cite> [<a href="https://doi.org/10.1002/EXP.20220141" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10582605/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37933289/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20G,%20Song%20Z,%20Ru%20Y,%20Zhang%20J,%20Luo%20L,%20Yang%20W,%20Wu%20H,%20Jin%20H,%20Bao%20X,%20Wei%20D,%20Yan%20Z,%20Qu%20H,%20Zhu%20Z,%20Xue%20X,%20Zhou%20G.%20Small-molecule%20nanoprodrug%20with%20high%20drug%20loading%20and%20EGFR,%20PI3K/AKT%20dual-inhibiting%20properties%20for%20bladder%20cancer%20treatment.%20Exploration.%202023;3:20220141." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Liu J, Chen C, Wei T, Gayet O, Loncle C, Borge L, Dusetti N, Ma X, Marson D, Laurini E, Pricl S, Gu Z, Iovanna J, Peng L, Liang XJ. Dendrimeric nanosystem consistently circumvents heterogeneous drug response and resistance in pancreatic cancer. Exploration. 2021;1:20210003.</cite> [<a href="https://doi.org/10.1002/EXP.20210003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10291567/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37366462/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20J,%20Chen%20C,%20Wei%20T,%20Gayet%20O,%20Loncle%20C,%20Borge%20L,%20Dusetti%20N,%20Ma%20X,%20Marson%20D,%20Laurini%20E,%20Pricl%20S,%20Gu%20Z,%20Iovanna%20J,%20Peng%20L,%20Liang%20XJ.%20Dendrimeric%20nanosystem%20consistently%20circumvents%20heterogeneous%20drug%20response%20and%20resistance%20in%20pancreatic%20cancer.%20Exploration.%202021;1:20210003." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG, van de Velde CJH, Watanabe T. Colorectal cancer. Nat Rev Dis Primers. 2015;1:15065.
</cite> [<a href="https://doi.org/10.1038/nrdp.2015.65" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4874655/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27189416/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kuipers%20EJ,%20Grady%20WM,%20Lieberman%20D,%20Seufferlein%20T,%20Sung%20JJ,%20Boelens%20PG,%20van%20de%20Velde%20CJH,%20Watanabe%20T.%20Colorectal%20cancer.%20Nat%20Rev%20Dis%20Primers.%202015;1:15065." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Liu X, Zhang X, Jiang S, Mo M, Wang Q, Wang Y, Zhou L, Hu S, Yang H, Hou Y, Chen Y, Lu X, Wang Y, Zhou X, Li W, Chang C, Yang X, Chen K, Cao J, Xu Q, Sun Y, Luo J, Luo Z, Hu X. Site-specific therapy guided by a 90-gene expression assay versus empirical chemotherapy in patients with cancer of unknown primary (Fudan CUP-001): a randomised controlled trial. Lancet Oncol. 2024;25(8):1092â€“102.
</cite> [<a href="https://doi.org/10.1016/S1470-2045(24)00313-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39068945/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20X,%20Zhang%20X,%20Jiang%20S,%20Mo%20M,%20Wang%20Q,%20Wang%20Y,%20Zhou%20L,%20Hu%20S,%20Yang%20H,%20Hou%20Y,%20Chen%20Y,%20Lu%20X,%20Wang%20Y,%20Zhou%20X,%20Li%20W,%20Chang%20C,%20Yang%20X,%20Chen%20K,%20Cao%20J,%20Xu%20Q,%20Sun%20Y,%20Luo%20J,%20Luo%20Z,%20Hu%20X.%20Site-specific%20therapy%20guided%20by%20a%2090-gene%20expression%20assay%20versus%20empirical%20chemotherapy%20in%20patients%20with%20cancer%20of%20unknown%20primary%20(Fudan%20CUP-001):%20a%20randomised%20controlled%20trial.%20Lancet%20Oncol.%202024;25(8):1092%E2%80%93102." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Peng K, Zheng Y, Xia W, Mao Z-W. Organometallic anti-tumor agents: targeting from biomolecules to dynamic bioprocesses. Chem Soc Rev. 2023;52(8):2790â€“832.
</cite> [<a href="https://doi.org/10.1039/d2cs00757f" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37014670/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Peng%20K,%20Zheng%20Y,%20Xia%20W,%20Mao%20Z-W.%20Organometallic%20anti-tumor%20agents:%20targeting%20from%20biomolecules%20to%20dynamic%20bioprocesses.%20Chem%20Soc%20Rev.%202023;52(8):2790%E2%80%93832." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Barenholz Y. Doxil<sup>Â®</sup>--the first FDA-approved nano-drug: lessons learned. J Control Release. 2012;160(2):117â€“34.
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2012.03.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22484195/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Barenholz%20Y.%20Doxil%C2%AE--the%20first%20FDA-approved%20nano-drug:%20lessons%20learned.%20J%20Control%20Release.%202012;160(2):117%E2%80%9334." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Yang B, Chen Y, Shi J. Tumor-specific chemotherapy by nanomedicine-enabled differential stress sensitization. Angew Chem Int Ed Engl. 2020;59(24):9693â€“701.
</cite> [<a href="https://doi.org/10.1002/anie.202002306" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32162453/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20B,%20Chen%20Y,%20Shi%20J.%20Tumor-specific%20chemotherapy%20by%20nanomedicine-enabled%20differential%20stress%20sensitization.%20Angew%20Chem%20Int%20Ed%20Engl.%202020;59(24):9693%E2%80%93701." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Hajipour MJ, Aghaverdi H, Serpooshan V, Vali H, Sheibani S, Mahmoudi M. Sex as an important factor in nanomedicine. Nat Commun. 2021;12(1):2984.
</cite> [<a href="https://doi.org/10.1038/s41467-021-23230-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8170671/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34017011/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hajipour%20MJ,%20Aghaverdi%20H,%20Serpooshan%20V,%20Vali%20H,%20Sheibani%20S,%20Mahmoudi%20M.%20Sex%20as%20an%20important%20factor%20in%20nanomedicine.%20Nat%20Commun.%202021;12(1):2984." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Wang Y, Deng W, Lee D, Yan L, Lu Y, Dong S, Huntoon K, Antony A, Li X, Ye R, Zhao Y, Zhao F, Schrank BR, Ha J, Kang M, Yang M, Gong P, Lorenzi PL, Tan L, Gallup TD, Tang SK, Yang Z, Li J, Sanford NN, Wang H, Kim BYS, Jiang W. Age-associated disparity in phagocytic clearance affects the efficacy of cancer nanotherapeutics. Nat Nanotechnol. 2024;19(2):255â€“63.
</cite> [<a href="https://doi.org/10.1038/s41565-023-01502-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12289334/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37723279/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Y,%20Deng%20W,%20Lee%20D,%20Yan%20L,%20Lu%20Y,%20Dong%20S,%20Huntoon%20K,%20Antony%20A,%20Li%20X,%20Ye%20R,%20Zhao%20Y,%20Zhao%20F,%20Schrank%20BR,%20Ha%20J,%20Kang%20M,%20Yang%20M,%20Gong%20P,%20Lorenzi%20PL,%20Tan%20L,%20Gallup%20TD,%20Tang%20SK,%20Yang%20Z,%20Li%20J,%20Sanford%20NN,%20Wang%20H,%20Kim%20BYS,%20Jiang%20W.%20Age-associated%20disparity%20in%20phagocytic%20clearance%20affects%20the%20efficacy%20of%20cancer%20nanotherapeutics.%20Nat%20Nanotechnol.%202024;19(2):255%E2%80%9363." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Wang Z, Aguilar EG, Luna JI, Dunai C, Khuat LT, Le CT, Mirsoian A, Minnar CM, Stoffel KM, Sturgill IR, Grossenbacher SK, Withers SS, Rebhun RB, Hartigan-Oâ€™Connor DS, MÃ©ndez-Lagares G, Tarantal AF, Isseroff RR, Griffith TS, Schalper KA, Merleev A, Saha A, Maverakis E, Kelly K, Aljumaily R, Ibrahimi S, Mukherjee S, Machiorlatti M, Vesely SK, Longo DL, Blazar BR, Canter RJ, Murphy WJ, Monjazeb AM. Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint Blockade. Nat Med. 2019;25(1):141â€“51.
</cite> [<a href="https://doi.org/10.1038/s41591-018-0221-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6324991/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30420753/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Z,%20Aguilar%20EG,%20Luna%20JI,%20Dunai%20C,%20Khuat%20LT,%20Le%20CT,%20Mirsoian%20A,%20Minnar%20CM,%20Stoffel%20KM,%20Sturgill%20IR,%20Grossenbacher%20SK,%20Withers%20SS,%20Rebhun%20RB,%20Hartigan-O%E2%80%99Connor%20DS,%20M%C3%A9ndez-Lagares%20G,%20Tarantal%20AF,%20Isseroff%20RR,%20Griffith%20TS,%20Schalper%20KA,%20Merleev%20A,%20Saha%20A,%20Maverakis%20E,%20Kelly%20K,%20Aljumaily%20R,%20Ibrahimi%20S,%20Mukherjee%20S,%20Machiorlatti%20M,%20Vesely%20SK,%20Longo%20DL,%20Blazar%20BR,%20Canter%20RJ,%20Murphy%20WJ,%20Monjazeb%20AM.%20Paradoxical%20effects%20of%20obesity%20on%20T%20cell%20function%20during%20tumor%20progression%20and%20PD-1%20checkpoint%20Blockade.%20Nat%20Med.%202019;25(1):141%E2%80%9351." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Stater EP, Sonay AY, Hart C, Grimm J. The ancillary effects of nanoparticles and their implications for nanomedicine. Nat Nanotechnol. 2021;16(11):1180â€“94.
</cite> [<a href="https://doi.org/10.1038/s41565-021-01017-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9031277/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34759355/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Stater%20EP,%20Sonay%20AY,%20Hart%20C,%20Grimm%20J.%20The%20ancillary%20effects%20of%20nanoparticles%20and%20their%20implications%20for%20nanomedicine.%20Nat%20Nanotechnol.%202021;16(11):1180%E2%80%9394." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Wheeler KE, Chetwynd AJ, Fahy KM, Hong BS, Tochihuitl JA, Foster LA, Lynch I. Environmental dimensions of the protein corona. Nat Nanotechnol. 2021;16(6):617â€“29.
</cite> [<a href="https://doi.org/10.1038/s41565-021-00924-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34117462/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wheeler%20KE,%20Chetwynd%20AJ,%20Fahy%20KM,%20Hong%20BS,%20Tochihuitl%20JA,%20Foster%20LA,%20Lynch%20I.%20Environmental%20dimensions%20of%20the%20protein%20corona.%20Nat%20Nanotechnol.%202021;16(6):617%E2%80%9329." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Xiao Q, Zoulikha M, Qiu M, Teng C, Lin C, Li X, Sallam MA, Xu Q, He W. The effects of protein Corona on in vivo fate of nanocarriers. Adv Drug Deliv Rev. 2022;186:114356.
</cite> [<a href="https://doi.org/10.1016/j.addr.2022.114356" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35595022/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xiao%20Q,%20Zoulikha%20M,%20Qiu%20M,%20Teng%20C,%20Lin%20C,%20Li%20X,%20Sallam%20MA,%20Xu%20Q,%20He%20W.%20The%20effects%20of%20protein%20Corona%20on%20in%20vivo%20fate%20of%20nanocarriers.%20Adv%20Drug%20Deliv%20Rev.%202022;186:114356." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Oh JY, Kim HS, Palanikumar L, Go EM, Jana B, Park SA, Kim HY, Kim K, Seo JK, Kwak SK, Kim C, Kang S, Ryu J. Cloaking nanoparticles with protein Corona shield for targeted drug delivery. Nat Commun. 2018;9(1):4548.
</cite> [<a href="https://doi.org/10.1038/s41467-018-06979-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6208370/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30382085/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Oh%20JY,%20Kim%20HS,%20Palanikumar%20L,%20Go%20EM,%20Jana%20B,%20Park%20SA,%20Kim%20HY,%20Kim%20K,%20Seo%20JK,%20Kwak%20SK,%20Kim%20C,%20Kang%20S,%20Ryu%20J.%20Cloaking%20nanoparticles%20with%20protein%20Corona%20shield%20for%20targeted%20drug%20delivery.%20Nat%20Commun.%202018;9(1):4548." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev. 2009;61(6):428â€“37.
</cite> [<a href="https://doi.org/10.1016/j.addr.2009.03.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3683962/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19376175/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Aggarwal%20P,%20Hall%20JB,%20McLeland%20CB,%20Dobrovolskaia%20MA,%20McNeil%20SE.%20Nanoparticle%20interaction%20with%20plasma%20proteins%20as%20it%20relates%20to%20particle%20biodistribution,%20biocompatibility%20and%20therapeutic%20efficacy.%20Adv%20Drug%20Deliv%20Rev.%202009;61(6):428%E2%80%9337." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Ju Y, Kelly HG, Dagley LF, Reynaldi A, Schlub TE, Spall SK, Bell CA, Cui J, Mitchell AJ, Lin Z, Wheatley AK, Thurecht KJ, Davenport MP, Webb AI, Caruso F, Kent SJ. Person-specific biomolecular coronas modulate nanoparticle interactions with immune cells in human blood. ACS Nano. 2020;14(11):15723â€“37.
</cite> [<a href="https://doi.org/10.1021/acsnano.0c06679" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33112593/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ju%20Y,%20Kelly%20HG,%20Dagley%20LF,%20Reynaldi%20A,%20Schlub%20TE,%20Spall%20SK,%20Bell%20CA,%20Cui%20J,%20Mitchell%20AJ,%20Lin%20Z,%20Wheatley%20AK,%20Thurecht%20KJ,%20Davenport%20MP,%20Webb%20AI,%20Caruso%20F,%20Kent%20SJ.%20Person-specific%20biomolecular%20coronas%20modulate%20nanoparticle%20interactions%20with%20immune%20cells%20in%20human%20blood.%20ACS%20Nano.%202020;14(11):15723%E2%80%9337." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Corbo C, Molinaro R, Tabatabaei M, Farokhzad OC, Mahmoudi M. Personalized protein corona on nanoparticles and its clinical implications. Biomater Sci. 2017;5(3):378â€“87.
</cite> [<a href="https://doi.org/10.1039/c6bm00921b" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5592724/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28133653/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Corbo%20C,%20Molinaro%20R,%20Tabatabaei%20M,%20Farokhzad%20OC,%20Mahmoudi%20M.%20Personalized%20protein%20corona%20on%20nanoparticles%20and%20its%20clinical%20implications.%20Biomater%20Sci.%202017;5(3):378%E2%80%9387." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Tao W, Lagergren J. Clinical management of obese patients with cancer. Nat Rev Clin Oncol. 2013;10(9):519â€“33.
</cite> [<a href="https://doi.org/10.1038/nrclinonc.2013.120" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23856746/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tao%20W,%20Lagergren%20J.%20Clinical%20management%20of%20obese%20patients%20with%20cancer.%20Nat%20Rev%20Clin%20Oncol.%202013;10(9):519%E2%80%9333." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Sung H, Siegel RL, Torre LA, Pearson-Stuttard J, Islami F, Fedewa SA, Goding Sauer A, Shuval K, Gapstur SM, Jacobs EJ, Giovannucci EL, Jemal A. Global patterns in excess body weight and the associated cancer burden. CA Cancer J Clin. 2019;69(2):88â€“112.
</cite> [<a href="https://doi.org/10.3322/caac.21499" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30548482/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sung%20H,%20Siegel%20RL,%20Torre%20LA,%20Pearson-Stuttard%20J,%20Islami%20F,%20Fedewa%20SA,%20Goding%20Sauer%20A,%20Shuval%20K,%20Gapstur%20SM,%20Jacobs%20EJ,%20Giovannucci%20EL,%20Jemal%20A.%20Global%20patterns%20in%20excess%20body%20weight%20and%20the%20associated%20cancer%20burden.%20CA%20Cancer%20J%20Clin.%202019;69(2):88%E2%80%93112." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Grossmann ME, Ray A, Nkhata KJ, Malakhov DA, Rogozina OP, Dogan S, Cleary MP. Obesity and breast cancer: status of leptin and adiponectin in pathological processes. Cancer Metastasis Rev. 2010;29(4):641â€“53.
</cite> [<a href="https://doi.org/10.1007/s10555-010-9252-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20821253/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Grossmann%20ME,%20Ray%20A,%20Nkhata%20KJ,%20Malakhov%20DA,%20Rogozina%20OP,%20Dogan%20S,%20Cleary%20MP.%20Obesity%20and%20breast%20cancer:%20status%20of%20leptin%20and%20adiponectin%20in%20pathological%20processes.%20Cancer%20Metastasis%20Rev.%202010;29(4):641%E2%80%9353." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Wolpin BM, Meyerhardt JA, Chan AT, Ng K, Chan JA, Wu K, Pollak MN, Giovannucci EL, Fuchs CS. Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. J Clin Oncol. 2009;27(2):176â€“85.
</cite> [<a href="https://doi.org/10.1200/JCO.2008.17.9945" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2645084/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19064975/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wolpin%20BM,%20Meyerhardt%20JA,%20Chan%20AT,%20Ng%20K,%20Chan%20JA,%20Wu%20K,%20Pollak%20MN,%20Giovannucci%20EL,%20Fuchs%20CS.%20Insulin,%20the%20insulin-like%20growth%20factor%20axis,%20and%20mortality%20in%20patients%20with%20nonmetastatic%20colorectal%20cancer.%20J%20Clin%20Oncol.%202009;27(2):176%E2%80%9385." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Weiss L, Melchardt T, Habringer S, Boekstegers A, Hufnagl C, Neureiter D, Hopfinger G, Greil R, Egle A. Increased body mass index is associated with improved overall survival in diffuse large B-cell lymphoma. Ann Oncol. 2014;25(1):171â€“6.
</cite> [<a href="https://doi.org/10.1093/annonc/mdt481" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24299961/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Weiss%20L,%20Melchardt%20T,%20Habringer%20S,%20Boekstegers%20A,%20Hufnagl%20C,%20Neureiter%20D,%20Hopfinger%20G,%20Greil%20R,%20Egle%20A.%20Increased%20body%20mass%20index%20is%20associated%20with%20improved%20overall%20survival%20in%20diffuse%20large%20B-cell%20lymphoma.%20Ann%20Oncol.%202014;25(1):171%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Chung KM, Singh J, Lawres L, Dorans KJ, Garcia C, Burkhardt DB, Robbins R, Bhutkar A, Cardone R, Zhao X, Babic A, Vayrynen SA, Dias Costa A, Nowak JA, Chang DT, Dunne RF, Hezel AF, Koong AC, Wilhelm JJ, Bellin MD, Nylander V, Gloyn AL, McCarthy MI, Kibbey RG, Krishnaswamy S, Wolpin BM, Jacks T, Fuchs CS, Muzumdar MD. Endocrine-exocrine signaling drives obesity-associated pancreatic ductal adenocarcinoma. Cell. 2020;181(4):832â€“47.
</cite> [<a href="https://doi.org/10.1016/j.cell.2020.03.062" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7266008/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32304665/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chung%20KM,%20Singh%20J,%20Lawres%20L,%20Dorans%20KJ,%20Garcia%20C,%20Burkhardt%20DB,%20Robbins%20R,%20Bhutkar%20A,%20Cardone%20R,%20Zhao%20X,%20Babic%20A,%20Vayrynen%20SA,%20Dias%20Costa%20A,%20Nowak%20JA,%20Chang%20DT,%20Dunne%20RF,%20Hezel%20AF,%20Koong%20AC,%20Wilhelm%20JJ,%20Bellin%20MD,%20Nylander%20V,%20Gloyn%20AL,%20McCarthy%20MI,%20Kibbey%20RG,%20Krishnaswamy%20S,%20Wolpin%20BM,%20Jacks%20T,%20Fuchs%20CS,%20Muzumdar%20MD.%20Endocrine-exocrine%20signaling%20drives%20obesity-associated%20pancreatic%20ductal%20adenocarcinoma.%20Cell.%202020;181(4):832%E2%80%9347." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Backes FJ, Nagel CI, Bussewitz E, Donner J, Hade E, Salani R. The impact of body weight on ovarian cancer outcomes. Int J Gynecol Cancer. 2011;21(9):1601â€“5.
</cite> [<a href="https://doi.org/10.1097/IGC.0b013e31822d2aa3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4175395/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21997171/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Backes%20FJ,%20Nagel%20CI,%20Bussewitz%20E,%20Donner%20J,%20Hade%20E,%20Salani%20R.%20The%20impact%20of%20body%20weight%20on%20ovarian%20cancer%20outcomes.%20Int%20J%20Gynecol%20Cancer.%202011;21(9):1601%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Pingili AK, Chaib M, Sipe LM, Miller EJ, Teng B, Sharma R, Yarbro JR, Asemota S, Al Abdallah Q, Mims TS, Marion TN, Daria D, Sekhri R, Hamilton AM, Troester MA, Jo H, Choi HY, Hayes DN, Cook KL, Narayanan R, Pierre JF, Makowski L. Immune checkpoint Blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancer. Cell Rep. 2021;35(12):109285.
</cite> [<a href="https://doi.org/10.1016/j.celrep.2021.109285" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8574993/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34161764/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pingili%20AK,%20Chaib%20M,%20Sipe%20LM,%20Miller%20EJ,%20Teng%20B,%20Sharma%20R,%20Yarbro%20JR,%20Asemota%20S,%20Al%20Abdallah%20Q,%20Mims%20TS,%20Marion%20TN,%20Daria%20D,%20Sekhri%20R,%20Hamilton%20AM,%20Troester%20MA,%20Jo%20H,%20Choi%20HY,%20Hayes%20DN,%20Cook%20KL,%20Narayanan%20R,%20Pierre%20JF,%20Makowski%20L.%20Immune%20checkpoint%20Blockade%20reprograms%20systemic%20immune%20landscape%20and%20tumor%20microenvironment%20in%20obesity-associated%20breast%20cancer.%20Cell%20Rep.%202021;35(12):109285." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Matulonis UA, Sood AK, Fallowfield L, Howitt BE, Sehouli J, Karlan BY. Ovarian cancer. Nat Rev Dis Primers. 2016;2:16061.
</cite> [<a href="https://doi.org/10.1038/nrdp.2016.61" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7290868/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27558151/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Matulonis%20UA,%20Sood%20AK,%20Fallowfield%20L,%20Howitt%20BE,%20Sehouli%20J,%20Karlan%20BY.%20Ovarian%20cancer.%20Nat%20Rev%20Dis%20Primers.%202016;2:16061." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Webb PM, Jordan SJ. Global epidemiology of epithelial ovarian cancer. Nature reviews. Clin Oncol. 2024;21(5):389â€“400.</cite> [<a href="https://doi.org/10.1038/s41571-024-00881-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38548868/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Webb%20PM,%20Jordan%20SJ.%20Global%20epidemiology%20of%20epithelial%20ovarian%20cancer.%20Nature%20reviews.%20Clin%20Oncol.%202024;21(5):389%E2%80%93400." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Zuo W, Chen W, Liu J, Huang S, Chen L, Liu Q, Liu N, Jin Q, Li Y, Wang P, Zhu X. Macrophage-mimic Hollow mesoporous Fe-based nanocatalysts for self-amplified chemodynamic therapy and metastasis Inhibition via tumor microenvironment remodeling. ACS Appl Mater Interfaces. 2022;14(4):5053â€“65.
</cite> [<a href="https://doi.org/10.1021/acsami.1c22432" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35040616/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zuo%20W,%20Chen%20W,%20Liu%20J,%20Huang%20S,%20Chen%20L,%20Liu%20Q,%20Liu%20N,%20Jin%20Q,%20Li%20Y,%20Wang%20P,%20Zhu%20X.%20Macrophage-mimic%20Hollow%20mesoporous%20Fe-based%20nanocatalysts%20for%20self-amplified%20chemodynamic%20therapy%20and%20metastasis%20Inhibition%20via%20tumor%20microenvironment%20remodeling.%20ACS%20Appl%20Mater%20Interfaces.%202022;14(4):5053%E2%80%9365." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Huang Y, Gu Z, Fan Y, Zhai G, Zhao X, Sun Q, Shi Y, Lin G. Inhibition of the adenosinergic pathway: the indispensable part of oncological therapy in the future. Purinergic Signal. 2019;15(1):53â€“67.
</cite> [<a href="https://doi.org/10.1007/s11302-018-9641-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6439062/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30809739/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20Y,%20Gu%20Z,%20Fan%20Y,%20Zhai%20G,%20Zhao%20X,%20Sun%20Q,%20Shi%20Y,%20Lin%20G.%20Inhibition%20of%20the%20adenosinergic%20pathway:%20the%20indispensable%20part%20of%20oncological%20therapy%20in%20the%20future.%20Purinergic%20Signal.%202019;15(1):53%E2%80%9367." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Huang Y, Shi Y, Wang Q, Qi T, Fu X, Gu Z, Zhang Y, Zhai G, Zhao X, Sun Q, Lin G. Enzyme responsiveness enhances the specificity and effectiveness of nanoparticles for the treatment of B16F10 melanoma. J Control Release. 2019;316:208â€“22.
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2019.10.052" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31682909/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20Y,%20Shi%20Y,%20Wang%20Q,%20Qi%20T,%20Fu%20X,%20Gu%20Z,%20Zhang%20Y,%20Zhai%20G,%20Zhao%20X,%20Sun%20Q,%20Lin%20G.%20Enzyme%20responsiveness%20enhances%20the%20specificity%20and%20effectiveness%20of%20nanoparticles%20for%20the%20treatment%20of%20B16F10%20melanoma.%20J%20Control%20Release.%202019;316:208%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Trivedi J, Yasir M, Maurya RK, Tripathi AS. Aptamer-based theranostics in oncology: design strategies and limitations. BIOI. 2024;5(1):7.</cite> [<a href="https://scholar.google.com/scholar_lookup?Trivedi%20J,%20Yasir%20M,%20Maurya%20RK,%20Tripathi%20AS.%20Aptamer-based%20theranostics%20in%20oncology:%20design%20strategies%20and%20limitations.%20BIOI.%202024;5(1):7." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Monach PA, Complement. Arthritis Rheumatol. 2024;76(1):1â€“8.
</cite> [<a href="https://doi.org/10.1002/art.42671" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37551641/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Monach%20PA,%20Complement.%20Arthritis%20Rheumatol.%202024;76(1):1%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Afshar-Kharghan V. The role of the complement system in cancer. J Clin Invest. 2017;127(3):780â€“9.
</cite> [<a href="https://doi.org/10.1172/JCI90962" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5330758/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28248200/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Afshar-Kharghan%20V.%20The%20role%20of%20the%20complement%20system%20in%20cancer.%20J%20Clin%20Invest.%202017;127(3):780%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Peerschke EIB, Ghebrehiwet B. cC1qR/CR and gC1qR/p33: observations in cancer. Mol Immunol. 2014;61(2):100â€“9.
</cite> [<a href="https://doi.org/10.1016/j.molimm.2014.06.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25044096/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Peerschke%20EIB,%20Ghebrehiwet%20B.%20cC1qR/CR%20and%20gC1qR/p33:%20observations%20in%20cancer.%20Mol%20Immunol.%202014;61(2):100%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Hosszu KK, Valentino A, Vinayagasundaram U, Vinayagasundaram R, Joyce MG, Ji Y, Peerschke EI, Ghebrehiwet B. DC-SIGN, C1q, and gC1qR form a trimolecular receptor complex on the surface of monocyte-derived immature dendritic cells. Blood. 2012;120(6):1228â€“36.
</cite> [<a href="https://doi.org/10.1182/blood-2011-07-369728" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3418718/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22700724/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hosszu%20KK,%20Valentino%20A,%20Vinayagasundaram%20U,%20Vinayagasundaram%20R,%20Joyce%20MG,%20Ji%20Y,%20Peerschke%20EI,%20Ghebrehiwet%20B.%20DC-SIGN,%20C1q,%20and%20gC1qR%20form%20a%20trimolecular%20receptor%20complex%20on%20the%20surface%20of%20monocyte-derived%20immature%20dendritic%20cells.%20Blood.%202012;120(6):1228%E2%80%9336." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Sherman M, Liu MM, Birnbaum S, Wolf SE, Minei JP, Gatson JW. Adult obese mice suffer from chronic secondary brain injury after mild TBI. J Neuroinflammation. 2016;13(1):171.
</cite> [<a href="https://doi.org/10.1186/s12974-016-0641-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4928296/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27357503/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sherman%20M,%20Liu%20MM,%20Birnbaum%20S,%20Wolf%20SE,%20Minei%20JP,%20Gatson%20JW.%20Adult%20obese%20mice%20suffer%20from%20chronic%20secondary%20brain%20injury%20after%20mild%20TBI.%20J%20Neuroinflammation.%202016;13(1):171." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Jiao W, Sang Y, Wang X, Wang S. Metabonomics and the gut Microbiome analysis of the effect of 6-shogaol on improving obesity. Food Chem. 2023;404:134734. Pt B).
</cite> [<a href="https://doi.org/10.1016/j.foodchem.2022.134734" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36327507/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jiao%20W,%20Sang%20Y,%20Wang%20X,%20Wang%20S.%20Metabonomics%20and%20the%20gut%20Microbiome%20analysis%20of%20the%20effect%20of%206-shogaol%20on%20improving%20obesity.%20Food%20Chem.%202023;404:134734.%20Pt%20B)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Prado CMM, Baracos VE, Xiao J, Birdsell L, StuyckensKim, Park YC, Parekh T, Sawyer MB. The association between body composition and toxicities from the combination of doxil and trabectedin in patients with advanced relapsed ovarian cancer. Appl Physiol Nutr Me. 2014;39(6):693â€“8.</cite> [<a href="https://doi.org/10.1139/apnm-2013-0403" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24869973/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Prado%20CMM,%20Baracos%20VE,%20Xiao%20J,%20Birdsell%20L,%20StuyckensKim,%20Park%20YC,%20Parekh%20T,%20Sawyer%20MB.%20The%20association%20between%20body%20composition%20and%20toxicities%20from%20the%20combination%20of%20doxil%20and%20trabectedin%20in%20patients%20with%20advanced%20relapsed%20ovarian%20cancer.%20Appl%20Physiol%20Nutr%20Me.%202014;39(6):693%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Sun L, Su Y, Jiao A, Wang X, Zhang B. T cells in health and disease. Signal Transduct Target Ther. 2023;8(1):235.
</cite> [<a href="https://doi.org/10.1038/s41392-023-01471-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10277291/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37332039/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sun%20L,%20Su%20Y,%20Jiao%20A,%20Wang%20X,%20Zhang%20B.%20T%20cells%20in%20health%20and%20disease.%20Signal%20Transduct%20Target%20Ther.%202023;8(1):235." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Cong Y, Qiao R, Wang X, Ji Y, Yang J, Baimanov D, Yu S, Cai R, Zhao Y, Wu X, Chen C, Wang L. Protein Corona-mediated Inhibition of nanozyme activity: impact of protein shape. J Am Chem Soc. 2024;146(15):10478â€“88.
</cite> [<a href="https://doi.org/10.1021/jacs.3c14046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38578196/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cong%20Y,%20Qiao%20R,%20Wang%20X,%20Ji%20Y,%20Yang%20J,%20Baimanov%20D,%20Yu%20S,%20Cai%20R,%20Zhao%20Y,%20Wu%20X,%20Chen%20C,%20Wang%20L.%20Protein%20Corona-mediated%20Inhibition%20of%20nanozyme%20activity:%20impact%20of%20protein%20shape.%20J%20Am%20Chem%20Soc.%202024;146(15):10478%E2%80%9388." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Zhang Y, Xiao W, He S, Xia X, Yang W, Yang Z, Hu H, Wang Y, Wang X, Li H, Huang Y, Gao H. Lipid-mediated protein corona regulation with increased Apolipoprotein A-I recruitment for glioma targeting. J Control Release. 2024;368:42â€“51.
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2024.02.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38365180/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20Y,%20Xiao%20W,%20He%20S,%20Xia%20X,%20Yang%20W,%20Yang%20Z,%20Hu%20H,%20Wang%20Y,%20Wang%20X,%20Li%20H,%20Huang%20Y,%20Gao%20H.%20Lipid-mediated%20protein%20corona%20regulation%20with%20increased%20Apolipoprotein%20A-I%20recruitment%20for%20glioma%20targeting.%20J%20Control%20Release.%202024;368:42%E2%80%9351." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Straub LG, Scherer PE. Metabolic messengers: adiponectin. Nat Metab. 2019;1(3):334â€“9.
</cite> [<a href="https://doi.org/10.1038/s42255-019-0041-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7357716/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32661510/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Straub%20LG,%20Scherer%20PE.%20Metabolic%20messengers:%20adiponectin.%20Nat%20Metab.%202019;1(3):334%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Ogden CA, deCathelineau A, Hoffmann PR, Bratton D, Ghebrehiwet B, Fadok VA, Henson PM. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med. 2001;194(6):781â€“95.
</cite> [<a href="https://doi.org/10.1084/jem.194.6.781" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2195958/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11560994/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ogden%20CA,%20deCathelineau%20A,%20Hoffmann%20PR,%20Bratton%20D,%20Ghebrehiwet%20B,%20Fadok%20VA,%20Henson%20PM.%20C1q%20and%20mannose%20binding%20lectin%20engagement%20of%20cell%20surface%20calreticulin%20and%20CD91%20initiates%20macropinocytosis%20and%20uptake%20of%20apoptotic%20cells.%20J%20Exp%20Med.%202001;194(6):781%E2%80%9395." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Perry VH, Oâ€™Connor V. C1q: the perfect complement for a synaptic feast? Nat Rev Neurosci. 2008;9(11):807â€“11.
</cite> [<a href="https://doi.org/10.1038/nrn2394" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18827829/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Perry%20VH,%20O%E2%80%99Connor%20V.%20C1q:%20the%20perfect%20complement%20for%20a%20synaptic%20feast?%20Nat%20Rev%20Neurosci.%202008;9(11):807%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>SchÃ¶ttler S, Becker G, Winzen S, Steinbach T, Mohr K, Landfester K, MailÃ¤nder V, Wurm FR. Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers. Nat Nanotechnol. 2016;11(4):372â€“7.
</cite> [<a href="https://doi.org/10.1038/nnano.2015.330" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26878141/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sch%C3%B6ttler%20S,%20Becker%20G,%20Winzen%20S,%20Steinbach%20T,%20Mohr%20K,%20Landfester%20K,%20Mail%C3%A4nder%20V,%20Wurm%20FR.%20Protein%20adsorption%20is%20required%20for%20stealth%20effect%20of%20poly(ethylene%20glycol)-%20and%20poly(phosphoester)-coated%20nanocarriers.%20Nat%20Nanotechnol.%202016;11(4):372%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Liu H, Xu S, Yong T, Wei Z, Bie N, Zhang X, Li X, Li J, Li S, Wang S, Zhao Y, Yang X, Gan L. Hydrophobicity-adaptive polymers trigger fission of tumor-cell-derived microparticles for enhanced anticancer drug delivery. Adv Mater. 2023;35(45):e2211980.
</cite> [<a href="https://doi.org/10.1002/adma.202211980" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37755231/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20H,%20Xu%20S,%20Yong%20T,%20Wei%20Z,%20Bie%20N,%20Zhang%20X,%20Li%20X,%20Li%20J,%20Li%20S,%20Wang%20S,%20Zhao%20Y,%20Yang%20X,%20Gan%20L.%20Hydrophobicity-adaptive%20polymers%20trigger%20fission%20of%20tumor-cell-derived%20microparticles%20for%20enhanced%20anticancer%20drug%20delivery.%20Adv%20Mater.%202023;35(45):e2211980." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Li Y, Wu W, Liu Q, Wu Q, Ren P, Xi X, Liu H, Zhao J, Zhang W, Wang Z, Lv Y, Tian B, Sun S, Cui J, Zhao Y, Wu J, Gao M, Chen F. Specific surface-modified iron oxide nanoparticles trigger complement-dependent innate and adaptive antileukaemia immunity. Nat Commun. 2024;15(1):10400.
</cite> [<a href="https://doi.org/10.1038/s41467-024-54810-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11607078/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39613769/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20Y,%20Wu%20W,%20Liu%20Q,%20Wu%20Q,%20Ren%20P,%20Xi%20X,%20Liu%20H,%20Zhao%20J,%20Zhang%20W,%20Wang%20Z,%20Lv%20Y,%20Tian%20B,%20Sun%20S,%20Cui%20J,%20Zhao%20Y,%20Wu%20J,%20Gao%20M,%20Chen%20F.%20Specific%20surface-modified%20iron%20oxide%20nanoparticles%20trigger%20complement-dependent%20innate%20and%20adaptive%20antileukaemia%20immunity.%20Nat%20Commun.%202024;15(1):10400." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Miao Y, Li L, Wang Y, Wang J, Zhou Y, Guo L, Zhao Y, Nie D, Zhang Y, Zhang X, Gan Y. Regulating protein corona on nanovesicles by glycosylated polyhydroxy polymer modification for efficient drug delivery. Nat Commun. 2024;15(1):1159.
</cite> [<a href="https://doi.org/10.1038/s41467-024-45254-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10850157/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38326312/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Miao%20Y,%20Li%20L,%20Wang%20Y,%20Wang%20J,%20Zhou%20Y,%20Guo%20L,%20Zhao%20Y,%20Nie%20D,%20Zhang%20Y,%20Zhang%20X,%20Gan%20Y.%20Regulating%20protein%20corona%20on%20nanovesicles%20by%20glycosylated%20polyhydroxy%20polymer%20modification%20for%20efficient%20drug%20delivery.%20Nat%20Commun.%202024;15(1):1159." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Hossain DMS, Javaid S, Cai M, Zhang C, Sawant A, Hinton M, Sathe M, Grein J, Blumenschein W, Pinheiro EM, Chackerian A. Dinaciclib induces Immunogenic cell death and enhances anti-PD1-mediated tumor suppression. J Clin Invest. 2018;128(2):644â€“54.
</cite> [<a href="https://doi.org/10.1172/JCI94586" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5785250/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29337311/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hossain%20DMS,%20Javaid%20S,%20Cai%20M,%20Zhang%20C,%20Sawant%20A,%20Hinton%20M,%20Sathe%20M,%20Grein%20J,%20Blumenschein%20W,%20Pinheiro%20EM,%20Chackerian%20A.%20Dinaciclib%20induces%20Immunogenic%20cell%20death%20and%20enhances%20anti-PD1-mediated%20tumor%20suppression.%20J%20Clin%20Invest.%202018;128(2):644%E2%80%9354." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Chung EY, Kim SJ, Ma XJ. Regulation of cytokine production during phagocytosis of apoptotic cells. Cell Res. 2006;16(2):154â€“61.
</cite> [<a href="https://doi.org/10.1038/sj.cr.7310021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16474428/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chung%20EY,%20Kim%20SJ,%20Ma%20XJ.%20Regulation%20of%20cytokine%20production%20during%20phagocytosis%20of%20apoptotic%20cells.%20Cell%20Res.%202006;16(2):154%E2%80%9361." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Torchinsky MB, Garaude J, Martin AP, Blander JM. Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation. Nature. 2009;458(7234):78â€“82.
</cite> [<a href="https://doi.org/10.1038/nature07781" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19262671/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Torchinsky%20MB,%20Garaude%20J,%20Martin%20AP,%20Blander%20JM.%20Innate%20immune%20recognition%20of%20infected%20apoptotic%20cells%20directs%20T(H)17%20cell%20differentiation.%20Nature.%202009;458(7234):78%E2%80%9382." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Pittoni V, Valesini G. The clearance of apoptotic cells: implications for autoimmunity. Autoimmun Rev. 2002;1(3):154â€“61.
</cite> [<a href="https://doi.org/10.1016/s1568-9972(02)00032-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12849009/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pittoni%20V,%20Valesini%20G.%20The%20clearance%20of%20apoptotic%20cells:%20implications%20for%20autoimmunity.%20Autoimmun%20Rev.%202002;1(3):154%E2%80%9361." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Clarke EV, Weist BM, Walsh CM, Tenner AJ. Complement protein C1q bound to apoptotic cells suppresses human macrophage and dendritic cell-mediated Th17 and Th1 T cell subset proliferation. J Leukoc Biol. 2015;97(1):147â€“60.
</cite> [<a href="https://doi.org/10.1189/jlb.3A0614-278R" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4377823/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25381385/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Clarke%20EV,%20Weist%20BM,%20Walsh%20CM,%20Tenner%20AJ.%20Complement%20protein%20C1q%20bound%20to%20apoptotic%20cells%20suppresses%20human%20macrophage%20and%20dendritic%20cell-mediated%20Th17%20and%20Th1%20T%20cell%20subset%20proliferation.%20J%20Leukoc%20Biol.%202015;97(1):147%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>West EE, Kemper C. Complosome - the intracellular complement system. Nat Rev Nephrol. 2023;19(7):426â€“39.
</cite> [<a href="https://doi.org/10.1038/s41581-023-00704-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10100629/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37055581/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?West%20EE,%20Kemper%20C.%20Complosome%20-%20the%20intracellular%20complement%20system.%20Nat%20Rev%20Nephrol.%202023;19(7):426%E2%80%9339." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12372299/bin/12951_2025_3635_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1.</a><sup> (4.5MB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>No datasets were generated or analysed during the current study.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Journal of Nanobiotechnology are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s12951-025-03635-0"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/12951_2025_Article_3635.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (3.0Â MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12372299/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12372299/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372299%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372299/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12372299/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12372299/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40847354/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12372299/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40847354/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12372299/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12372299/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="2f3H3HGrCOXKEjQpCLfIndKlmqS1vnF19Q2G5T5bbBhn0CTnjWGKVKXaDCc3z1Jm">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
